Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Breast Neoplasms: HELP
Hatem A. Azim
Based on 53 articles published since 2009
(Why 53 articles?)
||||
Expertise Level
The expertise of Hatem A. Azim ranks in the
  • Top 0.062%
  • ... of 265,285 published authors worldwide on Breast Neoplasms
  • ... from 2009 through 2019
  • ... based on contributions to 53 articles on the topic.
Graphical view (beta)
Get your prestigious
World Expert badge
similar to this:
 
Work Locations
Details
Most likely:    American University of Beirut      
2019
  • Department of Medicine, Institut Jules Bordet and Université Libre de Bruxelles (ULB), Brussels, Belgium. · Department of Hemato-Oncology, CISSS Montérégie-Centre/Hôpital Charles-Le Moyne, Université de Sherbrooke, Quebec, Canada. · Frontier Science, Kingussie, United Kingdom. · Breast International Group, Brussels, Belgium. · Novartis Pharma AG, Basel, Switzerland. · National Cancer Institute, Bethesda, Maryland. · Department of Medicine, Division of Hematology/Oncology, American University of Beirut, Beirut, Lebanon. · Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. · Rapid City Regional Hospital, Rapid City, South Dakota. · Breast Center, University of Ulm, Ulm, Germany. · Memorial Sloan Kettering Cancer Center, New York, New York. · Mayo Clinic, Jacksonville, Florida. · Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts. · Harvard TH Chan School of Public Health, Boston, Massachusetts. · Frontier Science and Technology Research Foundation, Boston, Massachusetts. · Pubmed 30335191
2018
  • Department of Medical Oncology and Breast Cancer Translational Research Laboratory, Institut Jules Bordet and Université Libre de Bruxelles (U.L.B.), Brussels, Belgium. Electronic address: · Medical Oncology, A.O. Ordine Mauriziano, Department of Oncology, University of Turin, Turin, Italy. · Breast Unit and Institute of Oncology of Southern Switzerland (IOSI), Geneva University Hospitals, Swiss Group for Clinical Cancer Research (SAKK), Lugano Viganello, Switzerland. · University of Milan, Department of Oncology and Hemato-Oncology, New Drugs and Early Drug Development for Innovative Therapies, European Institute of Oncology, IRCCS European School of Oncology (ESO), Milan, Italy. · Department of Medical Oncology and Breast Cancer Translational Research Laboratory, Institut Jules Bordet and Université Libre de Bruxelles (U.L.B.), Brussels, Belgium; Department of Medical Oncology, U.O. Sviluppo Terapie Innovative, Policlinico San Martino-IST, and Department of Internal Medicine and Medical Specialties (DIMI), School of Medicine, University of Genova, Genova, Italy. · Department of Medical Oncology, U.O. Sviluppo Terapie Innovative, Policlinico San Martino-IST, and Department of Internal Medicine and Medical Specialties (DIMI), School of Medicine, University of Genova, Genova, Italy. · Department of Oncology, Shaare Zedek Medical Centre, Jerusalem, Israel. · German Breast Group (GBG), Neu-Isenburg, and Centre for Haematology and Oncology, Frankfurt, Germany. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. · Fertility Clinic, Research Laboratory on Human Reproduction, CUB-Erasme and Université Libre de Bruxelles (U.L.B.), Brussels, Belgium. · Department of Medicine, Division of Hematology/Oncology, American University of Beirut (AUB), Beirut, Lebanon. · Fertility and Procreation Unit, Gynecologic Oncology Department, IRCCS European Institute of Oncology, European School of Oncology (ESO), Milan, Italy. · Pubmed 30170202
  • Dimitrios Zardavas and Debora Fumagalli, Breast International Group · Christos Sotiriou, Université Libre de Bruxelles, Brussels, Belgium · Luc te Marvelde and Roger L. Milne, Cancer Council · Roger L. Milne and Sherene Loi, University of Melbourne, Melbourne · Barry Iacopetta, University of Western Australia, Western Australia · Sandra O'Toole and Elena Lopez-Knowles, Garvan Institute of Medical Research, Darlinghurst, Australia · George Fountzilas and Vassiliki Kotoula, Hellenic Foundation for Cancer Research/Aristotle University of Thessaloniki, Thessaloniki · Evangelia Razis, Hygeia Hospital · George Papaxoinis, Hippokration Hospital, Athens, Greece · Heikki Joensuu, Helsinki University Hospital and University of Helsinki, Helsinki, Finland · Mary Ellen Moynahan, Memorial Sloan Kettering Cancer Center, New York, NY · Bryan T. Hennessy, Beaumont Hospital and Royal College of Surgeons, Dublin, Ireland · Ivan Bieche, Curie Institut, Paris · Thomas Bachelot, Centre de Recherche en Cancérologie de Lyon, Lyon · Stefan Michiels, Gustave Roussy and Inserm, Univ. Paris-Sud, Univ. Paris-Saclay, Villejuif, France · Lao H. Saal, Lund University, Lund · Olle Stal, Qing Wang, and Gizeh Perez-Tenorio, Linköping University, Linköping, Sweden · Jeanette Dupont Jensen, University of Southern Denmark, on behalf of the Danish Breast Cancer Cooperative Group, Odense, Denmark · Elena Lopez-Knowles, Royal Marsden NHS Trust and Institute of Cancer Research, London · Daniel W. Rea, University of Birmingham, Birmingham, United Kingdom · Mattia Barbaraeschi, Santa Chiara Hospital, Trento, Italy · Shinzaburo Noguchi, Osaka University, Osaka Japan · Hatem A. Azim Jr, American University of Beirut (AUB), Beirut, Lebanon · Enrique Lerma, Universitat Autònoma de Barcelona, Barcelona, Spain · Cornelis J.H. can de Velde, Leiden University Medical Center, Leiden, the Netherlands · Vicky Sabine, University of Guelph, Guelph · John M.S. Bartlett, Ontario Institute for Cancer Research, Toronto, Ontario, Canada. · Pubmed 29470143
  • Department of Medicine, Institut Jules Bordet and Université Libre de Bruxelles (ULB), Brussels, Belgium. · Data Centre, Institut Jules Bordet and Université Libre de Bruxelles (ULB), Brussels, Belgium. · European Institute of Oncology, Milan, Italy. · Department of Internal Medicine, Division of Hematology-Oncology, American University of Beirut (AUB), Beirut, Lebanon. · Pubmed 29329404
  • Hematology and Oncology department, Hôpital du Sacré-Coeur de Montréal, Montréal, Québec, Canada. · Department of Internal Medicine, American University of Beirut (AUB), Beirut, Lebanon. · Pubmed 29177472
  • Department of Medicine, Institut Jules Bordet and Université Libre de Bruxelles (ULB), Brussels, Belgium. · Department of Breast Surgery, University Hospital Herlev, Copenhagen, Denmark. · Data Centre, Institut Jules Bordet and Université Libre de Bruxelles (ULB), Brussels, Belgium. · Vall D'Hebron University Hospital, Barcelona, Spain. · La Paz University Hospital, Madrid, Spain. · Macerata Hospital, Macerata, Italy. · Danish Breast Cancer Group, Rigshospitalet, Copenhagen, Denmark. · International Breast Cancer Study Group Statistical Centre, Dana-Farber Cancer Institute, Boston, MA. · Department of Internal Medicine, American University of Beirut (AUB), Beirut, Lebanon. · European Institute of Oncology, Milan, Italy. · Pubmed 29087485
Probable:    Jules Bordet Institute      
2017
  • Breast Cancer Translational Research Laboratory, Institut Jules Bordet and Université Libre de Bruxelles (U.L.B.), Brussels, Belgium; Department of Medical Oncology, Institut Jules Bordet and Université Libre de Bruxelles (U.L.B.), Brussels, Belgium. Electronic address: · Fertility Clinic, Research Laboratory on Human Reproduction, CUB-Erasme, and Université Libre de Bruxelles (U.L.B.), Brussels, Belgium. · Department of Oncology and Hematology, University Hospital of Modena and Reggio Emilia, Modena, Italy. · Department of Medical Oncology, Institut Jules Bordet and Université Libre de Bruxelles (U.L.B.), Brussels, Belgium. · Fertility and Procreation Unit, Gynecologic Oncology Department, European Institute of Oncology, Milan, Italy. · Department of Medical Oncology, U.O. Sviluppo Terapie Innovative, IRCCS AOU San Martino-IST, Genova, Italy. · Pubmed 28750297
  • Hematology/Oncology Department, Hôpital du Sacré-Coeur de Montréal, Montreal, Quebec, Canada. · Frontier Science (Scotland) Ltd., Kincraig, UK. · Breast Data Center, Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Radiation Oncology Department, Hôpital Maisonneuve-Rosemont, Montreal, Quebec, Canada. · Novartis Pharma AG, Basel, Switzerland. · National Cancer Institute, Bethesda, MD, USA. · Oncology Division, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel. · Department of Oncology, Division of Cancer, Oslo University Hospital, Oslo, Norway. · Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway. · Medical Oncology Unit, Azienda Istituti Ospitalieri, Cremona, Italy. · Seattle Cancer Care Alliance, University of Washington, Seattle, WA, USA. · Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD, USA. · Case Western Reserve University, Cleveland, OH, USA. · Department of Surgery and Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria. · Department of Hematology/Oncology, Mayo Clinic, Jacksonville, FL, USA. · Pubmed 28376188
2016
  • European Institute of Oncology, Via Ripamonti, 435-20141 Milan, Italy. Electronic address: · Institut Jules Bordet, 121 Boulevard de Waterloo, 1000 Brussels, Belgium. · Pubmed 27371969
  • BrEAST Data Centre, Department of Medicine, Institut Jules Bordet, and l'Université Libre de Bruxelles (U.L.B.), Brussels, Belgium; Department of Medical Oncology, U.O. Oncologia Medica 2, IRCCS AOU San Martino-IST, Genoa, Italy. · Division of Epidemiology and Biostatistics, European Institute of Oncology, Milan, Italy. · Department of Medical Oncology, U.O. Sviluppo Terapie Innovative, IRCCS AOU San Martino-IST, Genoa, Italy. · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Brussels, Belgium. · USC Oncologia Medica, Azienda Ospedaliera "Papa Giovanni XXIII", Bergamo, Italy. · Department of Internal Medicine, University of Genoa, Unit of Clinical Epidemiology, IRCCS AOU San Martino-IST, Genoa, Italy. · Fertility and Procreation Unit, Division of Gynecologic Oncology, European Institute of Oncology, Milan, Italy. · BrEAST Data Centre, Department of Medicine, Institut Jules Bordet, and l'Université Libre de Bruxelles (U.L.B.), Brussels, Belgium; Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Brussels, Belgium. Electronic address: · Pubmed 27529149
  • a BrEAST Data Centre, Department of Medicine, Institut Jules Bordet , Université Libre de Bruxelles , Brussels , Belgium. · b Medicine Department, Institut Jules Bordet , Université Libre de Bruxelles , Brussels , Belgium. · Pubmed 27010772
  • Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium2Medical Oncology Clinic, Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Department of Breast and Gynecological Surgery, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Department of Pathology, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Institute of Molecular Medicine, University of Southern Denmark, Odense, Denmark6Danish Breast Cancer Cooperative Group, Copenhagen, Denmark. · Department of Pathology, European Institute of Oncology, University of Milan, Milan, Italy. · Avera Cancer Institute, Sioux Falls, South Dakota. · International Breast Cancer Study Group Statistical Center, Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, Massachusetts. · International Breast Cancer Study Group Coordinating Center and Central Pathology Office, Bern, Switzerland. · Institute of Molecular Medicine, University of Southern Denmark, Odense, Denmark6Danish Breast Cancer Cooperative Group, Copenhagen, Denmark11Department of Oncology, Odense University Hospital, Odense, Denmark12AgeCare, Odense University Hospital, Odense. · Medical Oncology Clinic, Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Service de Biostatistique et d'Epidémiologie, Gustave Roussy, Villejuif, France14INSERM U1018, CESP, Université Paris-Sud, Villejuif France. · Pubmed 26633571
  • Department of Medicine, BrEAST Data Centre, Institut Jules Bordet, and l'Université Libre de Bruxelles (U.L.B.), Boulevard de Waterloo 121, 1000 Brussels, Belgium. · Department of Medical Oncology, U.O. Oncologia Medica 2, IRCCS AOU San Martino-IST, Largo Rosanna Benzi 10, 16132 Genova, Italy. · Data Centre, Institut Jules Bordet, and l'Université Libre de Bruxelles (U.L.B.), Boulevard de Waterloo 121, 1000 Brussels, Belgium. · Department of Oncology, KU Leuven-University of Leuven, University Hospitals Leuven, B-3000 Leuven, Belgium. · Department of Medical Oncology, U.O. Sviluppo Terapie Innovative, IRCCS AOU San Martino-IST, Largo Rosanna Benzi 10, 16132 Genova, Italy. · Department of Medical and Biological Sciences, University of Udine, Piazzale Santa Maria della Misericordia 15, 33010 Udine, Italy. · Department of Oncology, University Hospital of Udine, Piazzale Santa Maria della Misericordia 15, 33010 Udine, Italy. · Department of Imaging and Pathology, Laboratory of Translational Cell & Tissue Research, KU Leuven-University of Leuven, B-3000 Leuven, Belgium. · Department of Pathology, KU Leuven-University of Leuven, University Hospitals Leuven, B-3000 Leuven, Belgium. · Department of General Medical Oncology, KU Leuven-University of Leuven, University Hospitals Leuven, B-3000 Leuven, Belgium. · Department of Gynecology and Obstetrics, KU Leuven-University of Leuven, University Hospitals Leuven, B-3000 Leuven, Belgium. · Pubmed 27802449
  • Obstetrics and Gynecology Department, Erasme Hospital, Brussels, Belgium; Research Laboratory on Human Reproduction, Université Libre de Bruxelles, Brussels, Belgium. Electronic address: · Research Laboratory on Human Reproduction, Université Libre de Bruxelles, Brussels, Belgium. Electronic address: · BrEAST Data Centre, Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Boulevard de Waterloo, 121, Brussels, Belgium. Electronic address: · Pubmed 26681116
2015
  • Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Pubmed 26352893
  • BrEAST Data Centre, Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Boulevard de Waterloo 125, B-1000 Brussels, Belgium. · Pubmed 25286972
  • Department of Medicine, BrEAST Data Centre, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Peter MacCallum Cancer Centre, Melbourne, Australia; Australia and New Zealand Breast Cancer Trials Group Newcastle, Australia; International Breast Cancer Study Group, Bern, Switzerland. · Swedish Breast Cancer Group, Universitetssjukhuset, Linkoping, Sweden. · Grupo Oncologico Cooperativo Chileno De Investigacion, Clinica Las Condes, Santiago, Chile. · International Drug Development Institute, Louvain-La-Neuve, Belgium. · University of Milan School of Medicine, and Department of Pathology, European Institute of Oncology, Milan, Italy. · Data Management Unit, Institut Jules Bordet, Université Libre de Bruxelles, Belgium. · Department of Oncology, Copenhagen University Hospital Rigshospitalet, and Danish Breast Cancer Cooperative Group, Copenhagen, Denmark. · Department of Hematology and Medical Oncology, Hospital Clínico Universitario de Valencia/INCLIVA, Universidad de Valencia, Spain(1). · Department of Surgery and Comprehensive Cancer Center, Medical University of Vienna, Austrian Breast and Colorectal Cancer Study Group, Vienna, Austria. · European Institute of Oncology, Milan, Italy; International Breast Cancer Study Group (IBCSG), Bern, Switzerland. · Sandro Pitigliani' Medical Oncology Department, Hospital of Prato, Istituto Toscano Tumori, Prato, Italy. · Medical Oncology Department, Hospital Santa Creu i Sant Pau, Medicine Department, Universitat Autònoma, Barcelona, Spain(1). · Department of Medical Oncology, University Hospital 12 de Octubre, Madrid, Spain. · St Vincet's University Hospital, Dublin 4, Ireland. Electronic address: · Pubmed 26074397
  • Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Boulevard de Waterloo, 121, Brussels, Belgium. · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Boulevard de Waterloo, 121, Brussels, Belgium. · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Boulevard de Waterloo, 121, Brussels, Belgium. · Department of Internal Medicine, University of Genova and IRCCS AOU San Martino - IST, Genoa, Italy. · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Boulevard de Waterloo, 121, Brussels, Belgium. · Pubmed 26467651
  • Obstetrics and Gynecology Department, Erasme Hospital, Brussels, Belgium; Research Laboratory on Human Reproduction, Université Libre de Bruxelles, Brussels, Belgium. Electronic address: · Danish Breast Cancer Cooperative Group, Righospitalet, Copenhagen, Denmark. Electronic address: · Fertility and Procreation in Oncology Unit, European Institute of Oncology, Milan, Italy. Electronic address: · Breast Cancer Unit, Service of Gynecology, Hospital Val d'Hebron, Barcelona, Spain. Electronic address: · Department of Oncology, Macerata Hospital, Italy. Electronic address: · Department of Gynaecology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark. Electronic address: · Research Laboratory on Human Reproduction, Université Libre de Bruxelles, Brussels, Belgium. Electronic address: · BrEAST Data Centre, Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. Electronic address: · Pubmed 26070684
  • BrEAST Data Centre, Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. Electronic address: · Division of Pathology, European Institute of Oncology, Milan, Italy. · Fertility and Procreation Unit, Department of Gynecology Oncology, European Institute of Oncology, Milan, Italy. · Division of Pathology, European Institute of Oncology, Milan, Italy; University of Milan, School of Medicine, Milan, Italy. · Division of Clinical Medicine and Research, Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, Victoria, Australia. · Pubmed 25702955
  • Oncology Institute of Southern Switzerland (IOSI), 6500 Bellinzona, Switzerland; International Breast Cancer Study Group (IBCSG), Effingerstrasse 40, 3008 Bern, Switzerland. Electronic address: · International Breast Cancer Study Group (IBCSG), Effingerstrasse 40, 3008 Bern, Switzerland. · Oncology Institute of Southern Switzerland (IOSI), 6500 Bellinzona, Switzerland. · School of Surgery, University of Western Australia, Perth, WA 6009, Australia. · Fertility & Procreation Unit, Division of Gynecologic Oncology, European Institute of Oncology (IEO), Via Ripamonti 435, 20141 Milan, Italy. · Breast Unit, Champalimaud Cancer Centre, Av. De Brasília, Doca de Pedrouços, 1400 - 038 Lisbon, Portugal. · Breast Cancer Service for Young Women, Oncology Institute, Sheba Medical Center, Tel Hashomer, 52621, Israel. · Woman and Fetal Imaging Clinic (WAFI), 2 Mohamed Farid Wagdy St., Suite41 Manial Al Roda Island, Cairo, Egypt. · Ospedale Multimedica, Viale Piemonte 70, Castellanza, VA, Italy. · Department of Oncology, King Abdul Aziz Medical City for National Guard, Riyadh, Saudi Arabia. · Oncology Department Macerata Hospital, Via S. Lucia 1, 62100 Macerata, Italy. · Sunnybrook Health Sciences Centre, Odette Cancer Centre, Medical Oncology, 2075 Bayview Avenue, Toronto, ON M4N 3M5, Canada. · Hereditary Cancer Clinic, Dpt of Medical Oncology, University Hospital of Heraklion, Voutes, Box 1352, Heraklion 71110, Greece. · Greeceo Unité d'oncologie, Ensemble hospitalier de la Côte, Hôpital de Morges, Morges and Centre pluridisciplinaire d'oncologie (CePO), CHUV, Lausanne, Switzerland. · CHUV-Centre d'Oncologie, Rue du Bugnon 46, 1011 Lausanne, Switzerland. · Universitätsklinik und Poliklinik für Medizinische Onkologie/Brust-und Tumor Zentrum der Frauenklinik, Inselspital, Freiburgstrasse, 3010 Bern, Switzerland. · IBCSG Statistical Center, Dana-Farber Cancer Institute, Frontier Science and Technology Research Foundation, Boston, MA, USA. · International Breast Cancer Study Group (IBCSG), Effingerstrasse 40, 3008 Bern, Switzerland; Program of Breast Health, European Institute of Oncology (IEO), Via Ripamonti, 435, 20141 Milano, Italy. · Division of Medical Oncology, University of Washington, Seattle, WA, USA. · Department of Medicine, BrEAST Data Centre, Institut Jules Bordet, Université Libre de, Bruxelles, Brussels, Belgium. · Dana-Farber Cancer Institute, 450 Brookline Avenue, Yawkey 12, Boston, MA 02215, USA. · Pubmed 25662412
2014
  • BrEAST Data Center, Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · BrEAST Data Center, Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · BrEAST Data Center, Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Pubmed 25336696
  • Institut Jules Bordet and Breast European Adjuvant Study Team, Brussels, Belgium. Electronic address: · Frontier Science (Scotland) Ltd, Grampian View, Kincraig, Kingussie, UK. · Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Istituto Nazionale del Tumori, Milan, Italy; SOLTI Breast Cancer Research Group, Spain. · GlaxoSmithKline, Collegeville, PA, USA. · Clinic for Gynaecology, Gynaecologic Oncology and Obstetrics and Breast Cancer Centre, HELIOS Klinikum Berlin, Buch, Germany. · Sana Klinikum Offenbach, Offenbach, Germany. · National Institute of Oncology, Budapest, Hungary. · Royal Marsden Hospital, London, UK; Institute of Cancer Research, London, UK. · Patricia Ritchie Centre for Cancer Care and Research, The University of Sydney, Mater Hospital, North Sydney, NSW, Australia. · Cancer Hospital, Chinese Academy of Medical Sciences, Beijing, China. · PUC-RS School of Medicine, Porto Alegre, Brazil. · Mayo Clinic, Jacksonville, FL, USA. · Institut Jules Bordet and Breast European Adjuvant Study Team, Brussels, Belgium. · Asian Medical Center, University of Ulsan College of Medicine, Seoul, South Korea. · Kliniken Essen-Mitte, Essen, Germany. · National Taiwan University Hospital, Taipei, Taiwan. · Clinique St-Elisabeth, Namur, Belgium. · Mackay Memorial Hospital, Taipei, Taiwan. · Kashirskoye Shosse, Moscow, Russia. · Cancer Institute "Prof Dr Ion Chiricuta", Cluj-Napoca, Romania. · Department of Medical Oncology, University of Pretoria, Pretoria, South Africa. · Odessa Oncology Centre, Odessa, Ukraine. · Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute and Frontier Science and Technology Research Foundation, Boston, MA, USA. · University Hospital Kiel, Kiel, Germany. · Memorial Sloan-Kettering Cancer Center, New York, NY, USA. · Pubmed 25130998
  • Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. · Oncology Institute of Southern Switzerland, Bellinzona, Switzerland; Breast Unit of Southern Switzerland, Bellinzona, Switzerland. · King Abdulaziz Medical City for National Guard, Riyadh, Saudi Arabia. · Luzerner Kantonsspital, Lucerne, Switzerland. · University Hospitals of Leuven, Leuven, Belgium. · Department of Medicine, BrEAST Data Centre, Jules Bordet Institute, Université Libre de Bruxelles, Brussels, Belgium. · European School of Oncology, Milan, Italy. · Institut Gustave Roussy, Villejuif, France. · Europa Donna, London, United Kingdom. · European Institute of Oncology, Milan, Italy. · Breast Center, Dept. OB&GYN, University of Munich (LMU), Munich, Germany. · Mater Misericordiae University Hospital, Dublin, Ireland. · German Breast Group, GBG Forschungs GmbH, Neu-Isenburg, Germany; Sana Klinikum Offenbach, Germany. · Sheba Medical Center, Ramat Gan, Israel. · European School of Oncology, Milan, Italy; European Institute of Oncology, Milan, Italy. · Sheba Medical Center, Tel Hashomer, Israel. · Breast Unit, Champalimaud Cancer Center, Lisbon, Portugal; European Institute of Oncology, Milan, Italy. Electronic address: · Pubmed 24767882
  • BrEAST Data Centre, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium · BrEAST Data Centre, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Frontier Science, Kincraig, Kingussie, Scotland. · Pubmed 25225439
2013
  • Department of Medicine, BrEAST Data Centre, Institut Jules Bordet, Université Libre de Bruxelles, Boulevard de Waterloo, 121, 1000 Brussels, Belgium. Electronic address: · Pubmed 24139068
  • Breast Cancer Translational Research Laboratory, J.C. Heuson, Université Libre de Bruxelles, Institut Jules Bordet, Brussels, Belgium; Department of Medicine, BrEAST Data Centre, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Pubmed 24060577
  • Jose Baselga, Memorial Sloan-Kettering Cancer Center, NY · James G. Greger Jr, GlaxoSmithKline, Collegeville, PA · Hatem A. Azim Jr, Martine Piccart, Evandro de Azambuja, BrEAST Data Centre, Institut Jules Bordet, Université Libre de Bruxelles · Phuong Dinh, Breast International Group, Brussels · Peter Vuylsteke, Sint-Elisabeth Hospital, Namur, Belgium · Dominique Agbor-tarh, Ian Bradbury, Frontier Science, Kincraig, Kingussie, Scotland · Ian Smith, Royal Marsden Hospital, and Institute of Cancer Research, London, United Kingdom · Serena Di Cosimo, IRCCS Fondazione Instituto Nazionale dei Tumori, Milan, Italy · Serena Di Cosimo, SOLTI Breast Cancer Research Group, Barcelona, Spain · Christian Jackisch, Kilinikum Offenbach, Offenbach · Bahriye Aktas, Kliniken Essen-Mitte, Evang, Essen · Holger Eidtmann, University Hospital Kiel, Kiel, Germany · Sung-Bae Kim, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea · Chiun-Sheng Huang, National Taiwan University Hospital · Ruey Kuen Hsieh, Mackey Memorial Hospital, Taipei, Taiwan · and Lydia Dreosti, University of Pretoria, Pretoria, South Africa. · Pubmed 24248687
  • Breast Cancer Translational Research Laboratory, JC Heuson, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Pubmed 23638089
  • Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Pubmed 23169515
2012
  • Breast Cancer Translational Research Laboratory J.C. Heuson, Université Libre de Bruxelles, Institut Jules Bordet, 1000 Brussels, Belgium. · Pubmed 22785217
  • Department of Medical Oncology, Institut Jules Bordet and l'Université Libre de Bruxelles, Boulevard de Waterloo 121, 1000 Brussels, Belgium. · Pubmed 22367645
  • Breast Cancer Translational Research Laboratory (BCTL) J.C. Heuson, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Pubmed 22261811
2011
  • Department of Medical Oncology, Jules Bordet Institute, Boulevard de Waterloo 121, 1000 Brussels, Belgium. · Pubmed 21342046
2016
  • Department of Medicine, Breast European Adjuvant Study Team (BrEAST) Data Centre, Institut Jules Bordet, Université Libre de Bruxelles (ULB), Brussels, Belgium (AS, EdA, MP, HAAJr); Frontier Science (Scotland) Ltd, Grampian View, Kincraig, Kingussie, UK (DAt, IB, CC); Novartis Pharmaceuticals Corporation, East Hanover, NJ (YH); Alliance Statistics and Data Center, Mayo Clinic, Section of Biostatistics, Scottsdale, AZ (ACD); Sunnybrook Odette Cancer Centre, the University of Toronto and the NCIC Clinical Trials Group, Toronto, Ontario, Canada (KIP); The Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD (ACW); Sana Klinikum Offenbach, Offenbach, Germany (CJ); National Institute of Oncology, Budapest, Hungary (IL); Helios Klinikum Berlin-Buch, Berlin, Germany (MU); Royal Marsden Hospital NHS Trust, Sutton/Surrey, UK (IS); Patricia Ritchie Centre for Cancer Care and Research, The University of Sydney, Mater Hospital, North Sydney, Australia (FB); Cancer Hospital, Chinese Academy of Medical Sciences, Beijing, China (BX); Instituto Nacional de Enfermedades Neoplasicas, Lima, Peru (HG); Mayo Clinic, Jacksonville, FL (EAP). · Department of Medicine, Breast European Adjuvant Study Team (BrEAST) Data Centre, Institut Jules Bordet, Université Libre de Bruxelles (ULB), Brussels, Belgium (AS, EdA, MP, HAAJr); Frontier Science (Scotland) Ltd, Grampian View, Kincraig, Kingussie, UK (DAt, IB, CC); Novartis Pharmaceuticals Corporation, East Hanover, NJ (YH); Alliance Statistics and Data Center, Mayo Clinic, Section of Biostatistics, Scottsdale, AZ (ACD); Sunnybrook Odette Cancer Centre, the University of Toronto and the NCIC Clinical Trials Group, Toronto, Ontario, Canada (KIP); The Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD (ACW); Sana Klinikum Offenbach, Offenbach, Germany (CJ); National Institute of Oncology, Budapest, Hungary (IL); Helios Klinikum Berlin-Buch, Berlin, Germany (MU); Royal Marsden Hospital NHS Trust, Sutton/Surrey, UK (IS); Patricia Ritchie Centre for Cancer Care and Research, The University of Sydney, Mater Hospital, North Sydney, Australia (FB); Cancer Hospital, Chinese Academy of Medical Sciences, Beijing, China (BX); Instituto Nacional de Enfermedades Neoplasicas, Lima, Peru (HG); Mayo Clinic, Jacksonville, FL (EAP) · Pubmed 27098150
  • From the Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium; University of Pittsburgh Cancer Institute and UPMC Cancer Center, Pittsburgh, PA; Department of Oncology, Mayo Clinic, Rochester, MN. · Pubmed 27249683
2014
  • Department of MedicineInstitut Jules Bordet, BrEAST Data Centre, Université Libre de Bruxelles (ULB), Boulevard de Waterloo, 121, 1000 Brussels, BelgiumBreast Cancer Translational Research Laboratory (BCTL) J. C. HeusonInstitut Jules Bordet, Université Libre de Bruxelles (ULB), Brussels, BelgiumFertility and Procreation UnitDepartment of Gynecologic Oncology, European Institute of Oncology, Milan, ItalyTranslational Breast Cancer Genomic LabCancer Therapeutics Program, Peter MacCallum Cancer Centre, East Melbourne, Victoria, AustraliaSir Peter MacCallum Department of OncologyUniversity of Melbourne, Parkville, Victoria, AustraliaVesalius Research CentreVIB, Leuven, BelgiumLaboratory of Translational GeneticsDepartment of Oncology, University of Leuven, Leuven, BelgiumDepartment of PathologyDivision of Epidemiology and BiostatisticsEuropean Institute of Oncology, Milan, ItalyDepartment of MedicineMedical Oncology Clinic, Institut Jules Bordet, Université Libre de Bruxelles (ULB), Brussels, BelgiumDepartment of MedicineInstitut Jules Bordet, BrEAST Data Centre, Université Libre de Bruxelles (ULB), Boulevard de Waterloo, 121, 1000 Brussels, BelgiumBreast Cancer Translational Research Laboratory (BCTL) J. C. HeusonInstitut Jules Bordet, Université Libre de Bruxelles (ULB), Brussels, BelgiumFertility and Procreation UnitDepartment of Gynecologic Oncology, European Institute of Oncology, Milan, ItalyTranslational Breast Cancer Genomic LabCancer Therapeutics Program, Peter MacCallum Cancer Centre, East Melbourne, Victoria, AustraliaSir Peter MacCallum Department of OncologyUniversity of Melbourne, Parkville, Victoria, AustraliaVesalius Research CentreVIB, Leuven, BelgiumLaboratory of Translational GeneticsDepartment of Oncology, University of Leuven, Leuven, BelgiumDepartment of PathologyDivision of Epidemiology and BiostatisticsEuropean Institute of Oncology, Milan, ItalyDepartment of MedicineMedical Oncology Clinic, Institut Jules Bordet, Université Libre de Bruxel · Department of MedicineInstitut Jules Bordet, BrEAST Data Centre, Université Libre de Bruxelles (ULB), Boulevard de Waterloo, 121, 1000 Brussels, BelgiumBreast Cancer Translational Research Laboratory (BCTL) J. C. HeusonInstitut Jules Bordet, Université Libre de Bruxelles (ULB), Brussels, BelgiumFertility and Procreation UnitDepartment of Gynecologic Oncology, European Institute of Oncology, Milan, ItalyTranslational Breast Cancer Genomic LabCancer Therapeutics Program, Peter MacCallum Cancer Centre, East Melbourne, Victoria, AustraliaSir Peter MacCallum Department of OncologyUniversity of Melbourne, Parkville, Victoria, AustraliaVesalius Research CentreVIB, Leuven, BelgiumLaboratory of Translational GeneticsDepartment of Oncology, University of Leuven, Leuven, BelgiumDepartment of PathologyDivision of Epidemiology and BiostatisticsEuropean Institute of Oncology, Milan, ItalyDepartment of MedicineMedical Oncology Clinic, Institut Jules Bordet, Université Libre de Bruxelles (ULB), Brussels, Belgium. · Pubmed 24825746
2012
  • Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Pubmed 22454417
2011
  • Department of Medical Oncology, Institut Jules Bordet, Universite Libre de Bruxelles, 1000 Brussels, Belgium. · Pubmed 21354372
Probable:    Universite Libre de Bruxelles      
2017
  • Breast Cancer Translational Research Laboratory, Institut Jules Bordet and Université Libre de Bruxelles (U.L.B.), Brussels, Belgium; Department of Medical Oncology, Institut Jules Bordet and Université Libre de Bruxelles (U.L.B.), Brussels, Belgium. Electronic address: · Fertility Clinic, Research Laboratory on Human Reproduction, CUB-Erasme, and Université Libre de Bruxelles (U.L.B.), Brussels, Belgium. · Department of Oncology and Hematology, University Hospital of Modena and Reggio Emilia, Modena, Italy. · Department of Medical Oncology, Institut Jules Bordet and Université Libre de Bruxelles (U.L.B.), Brussels, Belgium. · Fertility and Procreation Unit, Gynecologic Oncology Department, European Institute of Oncology, Milan, Italy. · Department of Medical Oncology, U.O. Sviluppo Terapie Innovative, IRCCS AOU San Martino-IST, Genova, Italy. · Pubmed 28750297
  • Hematology/Oncology Department, Hôpital du Sacré-Coeur de Montréal, Montreal, Quebec, Canada. · Frontier Science (Scotland) Ltd., Kincraig, UK. · Breast Data Center, Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Radiation Oncology Department, Hôpital Maisonneuve-Rosemont, Montreal, Quebec, Canada. · Novartis Pharma AG, Basel, Switzerland. · National Cancer Institute, Bethesda, MD, USA. · Oncology Division, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel. · Department of Oncology, Division of Cancer, Oslo University Hospital, Oslo, Norway. · Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway. · Medical Oncology Unit, Azienda Istituti Ospitalieri, Cremona, Italy. · Seattle Cancer Care Alliance, University of Washington, Seattle, WA, USA. · Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD, USA. · Case Western Reserve University, Cleveland, OH, USA. · Department of Surgery and Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria. · Department of Hematology/Oncology, Mayo Clinic, Jacksonville, FL, USA. · Pubmed 28376188
  • Amir Sonnenblick, Hadassah-Hebrew University Medical Center, Jerusalem, Israel · Dominique Agbor-Tarh and Ian Bradbury, Frontier Science, Kingussie, United Kingdom · Serena Di Cosimo Fondazione IRCCS, Istituto Nazionale dei Tumori, Milan, Italy · Hatem A. Azim Jr, Martine Piccart-Gebhart and Evandro de Azambuja, Université Libre de Bruxelles · Debora Fumagalli, Breast International Group, Brussels, Belgium · Severine Sarp, Novartis Pharma AG, Basel, Switzerland · Antonio C. Wolff, Johns Hopkins School of Medicine, Baltimore, MD · Lyndsay Harris, Case Western Reserve University School of Medicine, Cleveland, OH · Julie Gralow, Seattle Cancer Care Alliance, Seattle, WA · Alvaro Moreno-Aspitia, Mayo Clinic, Jacksonville, FL · Michael Andersson, Rigshospitalet University Hospital Copenhagen, Denmark · Judith Kroep, Leiden University Medical Center, Leiden, the Netherlands · Tanja Cufer, University Clinic Golnik Medical Faculty, Ljubljana, Slovenia · Sergio D. Simon, Hospital Israelita Albert Einstein · Sergio D. Simon, Grupo Brasileiro de Estudos do Cancer de Mama, São Paulo, Brazil · Pamela Salman, Fundación Arturo López Pérez, Santiago, Chile · Masakazu Toi, Kyoto University, Kyoto, Japan · Maccon Keane, University Hospital Galway, Galway · and Maccon Keane, Cancer Trials Ireland, Dublin, Ireland. · Pubmed 28375706
2016
  • a BrEAST Data Centre, Department of Medicine, Institut Jules Bordet , Université Libre de Bruxelles , Brussels , Belgium. · b Medicine Department, Institut Jules Bordet , Université Libre de Bruxelles , Brussels , Belgium. · Pubmed 27010772
  • Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium2Medical Oncology Clinic, Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Department of Breast and Gynecological Surgery, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Department of Pathology, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Institute of Molecular Medicine, University of Southern Denmark, Odense, Denmark6Danish Breast Cancer Cooperative Group, Copenhagen, Denmark. · Department of Pathology, European Institute of Oncology, University of Milan, Milan, Italy. · Avera Cancer Institute, Sioux Falls, South Dakota. · International Breast Cancer Study Group Statistical Center, Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, Massachusetts. · International Breast Cancer Study Group Coordinating Center and Central Pathology Office, Bern, Switzerland. · Institute of Molecular Medicine, University of Southern Denmark, Odense, Denmark6Danish Breast Cancer Cooperative Group, Copenhagen, Denmark11Department of Oncology, Odense University Hospital, Odense, Denmark12AgeCare, Odense University Hospital, Odense. · Medical Oncology Clinic, Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Service de Biostatistique et d'Epidémiologie, Gustave Roussy, Villejuif, France14INSERM U1018, CESP, Université Paris-Sud, Villejuif France. · Pubmed 26633571
  • Obstetrics and Gynecology Department, Erasme Hospital, Brussels, Belgium; Research Laboratory on Human Reproduction, Université Libre de Bruxelles, Brussels, Belgium. Electronic address: · Research Laboratory on Human Reproduction, Université Libre de Bruxelles, Brussels, Belgium. Electronic address: · BrEAST Data Centre, Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Boulevard de Waterloo, 121, Brussels, Belgium. Electronic address: · Pubmed 26681116
2015
  • Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Pubmed 26352893
  • BrEAST Data Centre, Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Boulevard de Waterloo 125, B-1000 Brussels, Belgium. · Pubmed 25286972
  • Department of Medicine, BrEAST Data Centre, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Peter MacCallum Cancer Centre, Melbourne, Australia; Australia and New Zealand Breast Cancer Trials Group Newcastle, Australia; International Breast Cancer Study Group, Bern, Switzerland. · Swedish Breast Cancer Group, Universitetssjukhuset, Linkoping, Sweden. · Grupo Oncologico Cooperativo Chileno De Investigacion, Clinica Las Condes, Santiago, Chile. · International Drug Development Institute, Louvain-La-Neuve, Belgium. · University of Milan School of Medicine, and Department of Pathology, European Institute of Oncology, Milan, Italy. · Data Management Unit, Institut Jules Bordet, Université Libre de Bruxelles, Belgium. · Department of Oncology, Copenhagen University Hospital Rigshospitalet, and Danish Breast Cancer Cooperative Group, Copenhagen, Denmark. · Department of Hematology and Medical Oncology, Hospital Clínico Universitario de Valencia/INCLIVA, Universidad de Valencia, Spain(1). · Department of Surgery and Comprehensive Cancer Center, Medical University of Vienna, Austrian Breast and Colorectal Cancer Study Group, Vienna, Austria. · European Institute of Oncology, Milan, Italy; International Breast Cancer Study Group (IBCSG), Bern, Switzerland. · Sandro Pitigliani' Medical Oncology Department, Hospital of Prato, Istituto Toscano Tumori, Prato, Italy. · Medical Oncology Department, Hospital Santa Creu i Sant Pau, Medicine Department, Universitat Autònoma, Barcelona, Spain(1). · Department of Medical Oncology, University Hospital 12 de Octubre, Madrid, Spain. · St Vincet's University Hospital, Dublin 4, Ireland. Electronic address: · Pubmed 26074397
  • Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Boulevard de Waterloo, 121, Brussels, Belgium. · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Boulevard de Waterloo, 121, Brussels, Belgium. · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Boulevard de Waterloo, 121, Brussels, Belgium. · Department of Internal Medicine, University of Genova and IRCCS AOU San Martino - IST, Genoa, Italy. · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Boulevard de Waterloo, 121, Brussels, Belgium. · Pubmed 26467651
  • Obstetrics and Gynecology Department, Erasme Hospital, Brussels, Belgium; Research Laboratory on Human Reproduction, Université Libre de Bruxelles, Brussels, Belgium. Electronic address: · Danish Breast Cancer Cooperative Group, Righospitalet, Copenhagen, Denmark. Electronic address: · Fertility and Procreation in Oncology Unit, European Institute of Oncology, Milan, Italy. Electronic address: · Breast Cancer Unit, Service of Gynecology, Hospital Val d'Hebron, Barcelona, Spain. Electronic address: · Department of Oncology, Macerata Hospital, Italy. Electronic address: · Department of Gynaecology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark. Electronic address: · Research Laboratory on Human Reproduction, Université Libre de Bruxelles, Brussels, Belgium. Electronic address: · BrEAST Data Centre, Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. Electronic address: · Pubmed 26070684
  • BrEAST Data Centre, Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. Electronic address: · Division of Pathology, European Institute of Oncology, Milan, Italy. · Fertility and Procreation Unit, Department of Gynecology Oncology, European Institute of Oncology, Milan, Italy. · Division of Pathology, European Institute of Oncology, Milan, Italy; University of Milan, School of Medicine, Milan, Italy. · Division of Clinical Medicine and Research, Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, Victoria, Australia. · Pubmed 25702955
  • Oncology Institute of Southern Switzerland (IOSI), 6500 Bellinzona, Switzerland; International Breast Cancer Study Group (IBCSG), Effingerstrasse 40, 3008 Bern, Switzerland. Electronic address: · International Breast Cancer Study Group (IBCSG), Effingerstrasse 40, 3008 Bern, Switzerland. · Oncology Institute of Southern Switzerland (IOSI), 6500 Bellinzona, Switzerland. · School of Surgery, University of Western Australia, Perth, WA 6009, Australia. · Fertility & Procreation Unit, Division of Gynecologic Oncology, European Institute of Oncology (IEO), Via Ripamonti 435, 20141 Milan, Italy. · Breast Unit, Champalimaud Cancer Centre, Av. De Brasília, Doca de Pedrouços, 1400 - 038 Lisbon, Portugal. · Breast Cancer Service for Young Women, Oncology Institute, Sheba Medical Center, Tel Hashomer, 52621, Israel. · Woman and Fetal Imaging Clinic (WAFI), 2 Mohamed Farid Wagdy St., Suite41 Manial Al Roda Island, Cairo, Egypt. · Ospedale Multimedica, Viale Piemonte 70, Castellanza, VA, Italy. · Department of Oncology, King Abdul Aziz Medical City for National Guard, Riyadh, Saudi Arabia. · Oncology Department Macerata Hospital, Via S. Lucia 1, 62100 Macerata, Italy. · Sunnybrook Health Sciences Centre, Odette Cancer Centre, Medical Oncology, 2075 Bayview Avenue, Toronto, ON M4N 3M5, Canada. · Hereditary Cancer Clinic, Dpt of Medical Oncology, University Hospital of Heraklion, Voutes, Box 1352, Heraklion 71110, Greece. · Greeceo Unité d'oncologie, Ensemble hospitalier de la Côte, Hôpital de Morges, Morges and Centre pluridisciplinaire d'oncologie (CePO), CHUV, Lausanne, Switzerland. · CHUV-Centre d'Oncologie, Rue du Bugnon 46, 1011 Lausanne, Switzerland. · Universitätsklinik und Poliklinik für Medizinische Onkologie/Brust-und Tumor Zentrum der Frauenklinik, Inselspital, Freiburgstrasse, 3010 Bern, Switzerland. · IBCSG Statistical Center, Dana-Farber Cancer Institute, Frontier Science and Technology Research Foundation, Boston, MA, USA. · International Breast Cancer Study Group (IBCSG), Effingerstrasse 40, 3008 Bern, Switzerland; Program of Breast Health, European Institute of Oncology (IEO), Via Ripamonti, 435, 20141 Milano, Italy. · Division of Medical Oncology, University of Washington, Seattle, WA, USA. · Department of Medicine, BrEAST Data Centre, Institut Jules Bordet, Université Libre de, Bruxelles, Brussels, Belgium. · Dana-Farber Cancer Institute, 450 Brookline Avenue, Yawkey 12, Boston, MA 02215, USA. · Pubmed 25662412
2014
  • BrEAST Data Center, Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · BrEAST Data Center, Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · BrEAST Data Center, Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Pubmed 25336696
  • Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. · Oncology Institute of Southern Switzerland, Bellinzona, Switzerland; Breast Unit of Southern Switzerland, Bellinzona, Switzerland. · King Abdulaziz Medical City for National Guard, Riyadh, Saudi Arabia. · Luzerner Kantonsspital, Lucerne, Switzerland. · University Hospitals of Leuven, Leuven, Belgium. · Department of Medicine, BrEAST Data Centre, Jules Bordet Institute, Université Libre de Bruxelles, Brussels, Belgium. · European School of Oncology, Milan, Italy. · Institut Gustave Roussy, Villejuif, France. · Europa Donna, London, United Kingdom. · European Institute of Oncology, Milan, Italy. · Breast Center, Dept. OB&GYN, University of Munich (LMU), Munich, Germany. · Mater Misericordiae University Hospital, Dublin, Ireland. · German Breast Group, GBG Forschungs GmbH, Neu-Isenburg, Germany; Sana Klinikum Offenbach, Germany. · Sheba Medical Center, Ramat Gan, Israel. · European School of Oncology, Milan, Italy; European Institute of Oncology, Milan, Italy. · Sheba Medical Center, Tel Hashomer, Israel. · Breast Unit, Champalimaud Cancer Center, Lisbon, Portugal; European Institute of Oncology, Milan, Italy. Electronic address: · Pubmed 24767882
  • BrEAST Data Centre, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium · BrEAST Data Centre, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Frontier Science, Kincraig, Kingussie, Scotland. · Pubmed 25225439
2013
  • Department of Medicine, BrEAST Data Centre, Institut Jules Bordet, Université Libre de Bruxelles, Boulevard de Waterloo, 121, 1000 Brussels, Belgium. Electronic address: · Pubmed 24139068
  • Breast Cancer Translational Research Laboratory, J.C. Heuson, Université Libre de Bruxelles, Institut Jules Bordet, Brussels, Belgium; Department of Medicine, BrEAST Data Centre, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Pubmed 24060577
  • Jose Baselga, Memorial Sloan-Kettering Cancer Center, NY · James G. Greger Jr, GlaxoSmithKline, Collegeville, PA · Hatem A. Azim Jr, Martine Piccart, Evandro de Azambuja, BrEAST Data Centre, Institut Jules Bordet, Université Libre de Bruxelles · Phuong Dinh, Breast International Group, Brussels · Peter Vuylsteke, Sint-Elisabeth Hospital, Namur, Belgium · Dominique Agbor-tarh, Ian Bradbury, Frontier Science, Kincraig, Kingussie, Scotland · Ian Smith, Royal Marsden Hospital, and Institute of Cancer Research, London, United Kingdom · Serena Di Cosimo, IRCCS Fondazione Instituto Nazionale dei Tumori, Milan, Italy · Serena Di Cosimo, SOLTI Breast Cancer Research Group, Barcelona, Spain · Christian Jackisch, Kilinikum Offenbach, Offenbach · Bahriye Aktas, Kliniken Essen-Mitte, Evang, Essen · Holger Eidtmann, University Hospital Kiel, Kiel, Germany · Sung-Bae Kim, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea · Chiun-Sheng Huang, National Taiwan University Hospital · Ruey Kuen Hsieh, Mackey Memorial Hospital, Taipei, Taiwan · and Lydia Dreosti, University of Pretoria, Pretoria, South Africa. · Pubmed 24248687
  • Breast Cancer Translational Research Laboratory, JC Heuson, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Pubmed 23638089
  • Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Pubmed 23169515
2012
  • Breast Cancer Translational Research Laboratory J.C. Heuson, Université Libre de Bruxelles, Institut Jules Bordet, 1000 Brussels, Belgium. · Pubmed 22785217
  • Breast Cancer Translational Research Laboratory (BCTL) J.C. Heuson, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Pubmed 22261811
2016
  • Department of Medicine, Breast European Adjuvant Study Team (BrEAST) Data Centre, Institut Jules Bordet, Université Libre de Bruxelles (ULB), Brussels, Belgium (AS, EdA, MP, HAAJr); Frontier Science (Scotland) Ltd, Grampian View, Kincraig, Kingussie, UK (DAt, IB, CC); Novartis Pharmaceuticals Corporation, East Hanover, NJ (YH); Alliance Statistics and Data Center, Mayo Clinic, Section of Biostatistics, Scottsdale, AZ (ACD); Sunnybrook Odette Cancer Centre, the University of Toronto and the NCIC Clinical Trials Group, Toronto, Ontario, Canada (KIP); The Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD (ACW); Sana Klinikum Offenbach, Offenbach, Germany (CJ); National Institute of Oncology, Budapest, Hungary (IL); Helios Klinikum Berlin-Buch, Berlin, Germany (MU); Royal Marsden Hospital NHS Trust, Sutton/Surrey, UK (IS); Patricia Ritchie Centre for Cancer Care and Research, The University of Sydney, Mater Hospital, North Sydney, Australia (FB); Cancer Hospital, Chinese Academy of Medical Sciences, Beijing, China (BX); Instituto Nacional de Enfermedades Neoplasicas, Lima, Peru (HG); Mayo Clinic, Jacksonville, FL (EAP). · Department of Medicine, Breast European Adjuvant Study Team (BrEAST) Data Centre, Institut Jules Bordet, Université Libre de Bruxelles (ULB), Brussels, Belgium (AS, EdA, MP, HAAJr); Frontier Science (Scotland) Ltd, Grampian View, Kincraig, Kingussie, UK (DAt, IB, CC); Novartis Pharmaceuticals Corporation, East Hanover, NJ (YH); Alliance Statistics and Data Center, Mayo Clinic, Section of Biostatistics, Scottsdale, AZ (ACD); Sunnybrook Odette Cancer Centre, the University of Toronto and the NCIC Clinical Trials Group, Toronto, Ontario, Canada (KIP); The Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD (ACW); Sana Klinikum Offenbach, Offenbach, Germany (CJ); National Institute of Oncology, Budapest, Hungary (IL); Helios Klinikum Berlin-Buch, Berlin, Germany (MU); Royal Marsden Hospital NHS Trust, Sutton/Surrey, UK (IS); Patricia Ritchie Centre for Cancer Care and Research, The University of Sydney, Mater Hospital, North Sydney, Australia (FB); Cancer Hospital, Chinese Academy of Medical Sciences, Beijing, China (BX); Instituto Nacional de Enfermedades Neoplasicas, Lima, Peru (HG); Mayo Clinic, Jacksonville, FL (EAP) · Pubmed 27098150
  • From the Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium; University of Pittsburgh Cancer Institute and UPMC Cancer Center, Pittsburgh, PA; Department of Oncology, Mayo Clinic, Rochester, MN. · Pubmed 27249683
2014
  • Department of MedicineInstitut Jules Bordet, BrEAST Data Centre, Université Libre de Bruxelles (ULB), Boulevard de Waterloo, 121, 1000 Brussels, BelgiumBreast Cancer Translational Research Laboratory (BCTL) J. C. HeusonInstitut Jules Bordet, Université Libre de Bruxelles (ULB), Brussels, BelgiumFertility and Procreation UnitDepartment of Gynecologic Oncology, European Institute of Oncology, Milan, ItalyTranslational Breast Cancer Genomic LabCancer Therapeutics Program, Peter MacCallum Cancer Centre, East Melbourne, Victoria, AustraliaSir Peter MacCallum Department of OncologyUniversity of Melbourne, Parkville, Victoria, AustraliaVesalius Research CentreVIB, Leuven, BelgiumLaboratory of Translational GeneticsDepartment of Oncology, University of Leuven, Leuven, BelgiumDepartment of PathologyDivision of Epidemiology and BiostatisticsEuropean Institute of Oncology, Milan, ItalyDepartment of MedicineMedical Oncology Clinic, Institut Jules Bordet, Université Libre de Bruxelles (ULB), Brussels, BelgiumDepartment of MedicineInstitut Jules Bordet, BrEAST Data Centre, Université Libre de Bruxelles (ULB), Boulevard de Waterloo, 121, 1000 Brussels, BelgiumBreast Cancer Translational Research Laboratory (BCTL) J. C. HeusonInstitut Jules Bordet, Université Libre de Bruxelles (ULB), Brussels, BelgiumFertility and Procreation UnitDepartment of Gynecologic Oncology, European Institute of Oncology, Milan, ItalyTranslational Breast Cancer Genomic LabCancer Therapeutics Program, Peter MacCallum Cancer Centre, East Melbourne, Victoria, AustraliaSir Peter MacCallum Department of OncologyUniversity of Melbourne, Parkville, Victoria, AustraliaVesalius Research CentreVIB, Leuven, BelgiumLaboratory of Translational GeneticsDepartment of Oncology, University of Leuven, Leuven, BelgiumDepartment of PathologyDivision of Epidemiology and BiostatisticsEuropean Institute of Oncology, Milan, ItalyDepartment of MedicineMedical Oncology Clinic, Institut Jules Bordet, Université Libre de Bruxel · Department of MedicineInstitut Jules Bordet, BrEAST Data Centre, Université Libre de Bruxelles (ULB), Boulevard de Waterloo, 121, 1000 Brussels, BelgiumBreast Cancer Translational Research Laboratory (BCTL) J. C. HeusonInstitut Jules Bordet, Université Libre de Bruxelles (ULB), Brussels, BelgiumFertility and Procreation UnitDepartment of Gynecologic Oncology, European Institute of Oncology, Milan, ItalyTranslational Breast Cancer Genomic LabCancer Therapeutics Program, Peter MacCallum Cancer Centre, East Melbourne, Victoria, AustraliaSir Peter MacCallum Department of OncologyUniversity of Melbourne, Parkville, Victoria, AustraliaVesalius Research CentreVIB, Leuven, BelgiumLaboratory of Translational GeneticsDepartment of Oncology, University of Leuven, Leuven, BelgiumDepartment of PathologyDivision of Epidemiology and BiostatisticsEuropean Institute of Oncology, Milan, ItalyDepartment of MedicineMedical Oncology Clinic, Institut Jules Bordet, Université Libre de Bruxelles (ULB), Brussels, Belgium. · Pubmed 24825746
2012
  • Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Pubmed 22454417
2011
  • Department of Medical Oncology, Institut Jules Bordet, Universite Libre de Bruxelles, 1000 Brussels, Belgium. · Pubmed 21354372
Show More
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of the 10 most recent articles (out of 53 total) written by Hatem A. Azim about Breast Neoplasms:

  • Pregnancies during and after trastuzumab and/or lapatinib in patients with human epidermal growth factor receptor 2-positive early breast cancer: Analysis from the NeoALTTO (BIG 1-06) and ALTTO (BIG 2-06) trials. 2019
  • The BCY3/BCC 2017 survey on physicians' knowledge, attitudes and practice towards fertility and pregnancy-related issues in young breast cancer patients. 2018
  • Tumor PIK3CA Genotype and Prognosis in Early-Stage Breast Cancer: A Pooled Analysis of Individual Patient Data. 2018
  • Response. 2018
  • Response. 2018
  • Long-term Safety of Pregnancy Following Breast Cancer According to Estrogen Receptor Status. 2018
  • Fertility and pregnancy issues in BRCA-mutated breast cancer patients. 2017
  • Regional Nodal Irradiation After Breast Conserving Surgery for Early HER2-Positive Breast Cancer: Results of a Subanalysis From the ALTTO Trial. 2017
  • Impact of Diabetes, Insulin, and Metformin Use on the Outcome of Patients With Human Epidermal Growth Factor Receptor 2-Positive Primary Breast Cancer: Analysis From the ALTTO Phase III Randomized Trial. 2017
  • Managing pregnancy-associated breast cancer: Is more really better? 2016
Show List of Full Article Records
Google Searches

Learn more about Hatem A. Azim using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
American University of Beirut
Jules Bordet Institute
Universite Libre de Bruxelles
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
American University of Beirut
2019
  • Department of Medicine, Institut Jules Bordet and Université Libre de Bruxelles (ULB), Brussels, Belgium. · Department of Hemato-Oncology, CISSS Montérégie-Centre/Hôpital Charles-Le Moyne, Université de Sherbrooke, Quebec, Canada. · Frontier Science, Kingussie, United Kingdom. · Breast International Group, Brussels, Belgium. · Novartis Pharma AG, Basel, Switzerland. · National Cancer Institute, Bethesda, Maryland. · Department of Medicine, Division of Hematology/Oncology, American University of Beirut, Beirut, Lebanon. · Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. · Rapid City Regional Hospital, Rapid City, South Dakota. · Breast Center, University of Ulm, Ulm, Germany. · Memorial Sloan Kettering Cancer Center, New York, New York. · Mayo Clinic, Jacksonville, Florida. · Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts. · Harvard TH Chan School of Public Health, Boston, Massachusetts. · Frontier Science and Technology Research Foundation, Boston, Massachusetts. · Pubmed 30335191
2018
  • Department of Medical Oncology and Breast Cancer Translational Research Laboratory, Institut Jules Bordet and Université Libre de Bruxelles (U.L.B.), Brussels, Belgium. Electronic address: · Medical Oncology, A.O. Ordine Mauriziano, Department of Oncology, University of Turin, Turin, Italy. · Breast Unit and Institute of Oncology of Southern Switzerland (IOSI), Geneva University Hospitals, Swiss Group for Clinical Cancer Research (SAKK), Lugano Viganello, Switzerland. · University of Milan, Department of Oncology and Hemato-Oncology, New Drugs and Early Drug Development for Innovative Therapies, European Institute of Oncology, IRCCS European School of Oncology (ESO), Milan, Italy. · Department of Medical Oncology and Breast Cancer Translational Research Laboratory, Institut Jules Bordet and Université Libre de Bruxelles (U.L.B.), Brussels, Belgium; Department of Medical Oncology, U.O. Sviluppo Terapie Innovative, Policlinico San Martino-IST, and Department of Internal Medicine and Medical Specialties (DIMI), School of Medicine, University of Genova, Genova, Italy. · Department of Medical Oncology, U.O. Sviluppo Terapie Innovative, Policlinico San Martino-IST, and Department of Internal Medicine and Medical Specialties (DIMI), School of Medicine, University of Genova, Genova, Italy. · Department of Oncology, Shaare Zedek Medical Centre, Jerusalem, Israel. · German Breast Group (GBG), Neu-Isenburg, and Centre for Haematology and Oncology, Frankfurt, Germany. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. · Fertility Clinic, Research Laboratory on Human Reproduction, CUB-Erasme and Université Libre de Bruxelles (U.L.B.), Brussels, Belgium. · Department of Medicine, Division of Hematology/Oncology, American University of Beirut (AUB), Beirut, Lebanon. · Fertility and Procreation Unit, Gynecologic Oncology Department, IRCCS European Institute of Oncology, European School of Oncology (ESO), Milan, Italy. · Pubmed 30170202
  • Dimitrios Zardavas and Debora Fumagalli, Breast International Group · Christos Sotiriou, Université Libre de Bruxelles, Brussels, Belgium · Luc te Marvelde and Roger L. Milne, Cancer Council · Roger L. Milne and Sherene Loi, University of Melbourne, Melbourne · Barry Iacopetta, University of Western Australia, Western Australia · Sandra O'Toole and Elena Lopez-Knowles, Garvan Institute of Medical Research, Darlinghurst, Australia · George Fountzilas and Vassiliki Kotoula, Hellenic Foundation for Cancer Research/Aristotle University of Thessaloniki, Thessaloniki · Evangelia Razis, Hygeia Hospital · George Papaxoinis, Hippokration Hospital, Athens, Greece · Heikki Joensuu, Helsinki University Hospital and University of Helsinki, Helsinki, Finland · Mary Ellen Moynahan, Memorial Sloan Kettering Cancer Center, New York, NY · Bryan T. Hennessy, Beaumont Hospital and Royal College of Surgeons, Dublin, Ireland · Ivan Bieche, Curie Institut, Paris · Thomas Bachelot, Centre de Recherche en Cancérologie de Lyon, Lyon · Stefan Michiels, Gustave Roussy and Inserm, Univ. Paris-Sud, Univ. Paris-Saclay, Villejuif, France · Lao H. Saal, Lund University, Lund · Olle Stal, Qing Wang, and Gizeh Perez-Tenorio, Linköping University, Linköping, Sweden · Jeanette Dupont Jensen, University of Southern Denmark, on behalf of the Danish Breast Cancer Cooperative Group, Odense, Denmark · Elena Lopez-Knowles, Royal Marsden NHS Trust and Institute of Cancer Research, London · Daniel W. Rea, University of Birmingham, Birmingham, United Kingdom · Mattia Barbaraeschi, Santa Chiara Hospital, Trento, Italy · Shinzaburo Noguchi, Osaka University, Osaka Japan · Hatem A. Azim Jr, American University of Beirut (AUB), Beirut, Lebanon · Enrique Lerma, Universitat Autònoma de Barcelona, Barcelona, Spain · Cornelis J.H. can de Velde, Leiden University Medical Center, Leiden, the Netherlands · Vicky Sabine, University of Guelph, Guelph · John M.S. Bartlett, Ontario Institute for Cancer Research, Toronto, Ontario, Canada. · Pubmed 29470143
  • Department of Medicine, Institut Jules Bordet and Université Libre de Bruxelles (ULB), Brussels, Belgium. · Data Centre, Institut Jules Bordet and Université Libre de Bruxelles (ULB), Brussels, Belgium. · European Institute of Oncology, Milan, Italy. · Department of Internal Medicine, Division of Hematology-Oncology, American University of Beirut (AUB), Beirut, Lebanon. · Pubmed 29329404
  • Hematology and Oncology department, Hôpital du Sacré-Coeur de Montréal, Montréal, Québec, Canada. · Department of Internal Medicine, American University of Beirut (AUB), Beirut, Lebanon. · Pubmed 29177472
  • Department of Medicine, Institut Jules Bordet and Université Libre de Bruxelles (ULB), Brussels, Belgium. · Department of Breast Surgery, University Hospital Herlev, Copenhagen, Denmark. · Data Centre, Institut Jules Bordet and Université Libre de Bruxelles (ULB), Brussels, Belgium. · Vall D'Hebron University Hospital, Barcelona, Spain. · La Paz University Hospital, Madrid, Spain. · Macerata Hospital, Macerata, Italy. · Danish Breast Cancer Group, Rigshospitalet, Copenhagen, Denmark. · International Breast Cancer Study Group Statistical Centre, Dana-Farber Cancer Institute, Boston, MA. · Department of Internal Medicine, American University of Beirut (AUB), Beirut, Lebanon. · European Institute of Oncology, Milan, Italy. · Pubmed 29087485
Jules Bordet Institute
2017
  • Breast Cancer Translational Research Laboratory, Institut Jules Bordet and Université Libre de Bruxelles (U.L.B.), Brussels, Belgium; Department of Medical Oncology, Institut Jules Bordet and Université Libre de Bruxelles (U.L.B.), Brussels, Belgium. Electronic address: · Fertility Clinic, Research Laboratory on Human Reproduction, CUB-Erasme, and Université Libre de Bruxelles (U.L.B.), Brussels, Belgium. · Department of Oncology and Hematology, University Hospital of Modena and Reggio Emilia, Modena, Italy. · Department of Medical Oncology, Institut Jules Bordet and Université Libre de Bruxelles (U.L.B.), Brussels, Belgium. · Fertility and Procreation Unit, Gynecologic Oncology Department, European Institute of Oncology, Milan, Italy. · Department of Medical Oncology, U.O. Sviluppo Terapie Innovative, IRCCS AOU San Martino-IST, Genova, Italy. · Pubmed 28750297
  • Hematology/Oncology Department, Hôpital du Sacré-Coeur de Montréal, Montreal, Quebec, Canada. · Frontier Science (Scotland) Ltd., Kincraig, UK. · Breast Data Center, Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Radiation Oncology Department, Hôpital Maisonneuve-Rosemont, Montreal, Quebec, Canada. · Novartis Pharma AG, Basel, Switzerland. · National Cancer Institute, Bethesda, MD, USA. · Oncology Division, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel. · Department of Oncology, Division of Cancer, Oslo University Hospital, Oslo, Norway. · Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway. · Medical Oncology Unit, Azienda Istituti Ospitalieri, Cremona, Italy. · Seattle Cancer Care Alliance, University of Washington, Seattle, WA, USA. · Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD, USA. · Case Western Reserve University, Cleveland, OH, USA. · Department of Surgery and Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria. · Department of Hematology/Oncology, Mayo Clinic, Jacksonville, FL, USA. · Pubmed 28376188
2016
  • European Institute of Oncology, Via Ripamonti, 435-20141 Milan, Italy. Electronic address: · Institut Jules Bordet, 121 Boulevard de Waterloo, 1000 Brussels, Belgium. · Pubmed 27371969
  • BrEAST Data Centre, Department of Medicine, Institut Jules Bordet, and l'Université Libre de Bruxelles (U.L.B.), Brussels, Belgium; Department of Medical Oncology, U.O. Oncologia Medica 2, IRCCS AOU San Martino-IST, Genoa, Italy. · Division of Epidemiology and Biostatistics, European Institute of Oncology, Milan, Italy. · Department of Medical Oncology, U.O. Sviluppo Terapie Innovative, IRCCS AOU San Martino-IST, Genoa, Italy. · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Brussels, Belgium. · USC Oncologia Medica, Azienda Ospedaliera "Papa Giovanni XXIII", Bergamo, Italy. · Department of Internal Medicine, University of Genoa, Unit of Clinical Epidemiology, IRCCS AOU San Martino-IST, Genoa, Italy. · Fertility and Procreation Unit, Division of Gynecologic Oncology, European Institute of Oncology, Milan, Italy. · BrEAST Data Centre, Department of Medicine, Institut Jules Bordet, and l'Université Libre de Bruxelles (U.L.B.), Brussels, Belgium; Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Brussels, Belgium. Electronic address: · Pubmed 27529149
  • a BrEAST Data Centre, Department of Medicine, Institut Jules Bordet , Université Libre de Bruxelles , Brussels , Belgium. · b Medicine Department, Institut Jules Bordet , Université Libre de Bruxelles , Brussels , Belgium. · Pubmed 27010772
  • Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium2Medical Oncology Clinic, Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Department of Breast and Gynecological Surgery, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Department of Pathology, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Institute of Molecular Medicine, University of Southern Denmark, Odense, Denmark6Danish Breast Cancer Cooperative Group, Copenhagen, Denmark. · Department of Pathology, European Institute of Oncology, University of Milan, Milan, Italy. · Avera Cancer Institute, Sioux Falls, South Dakota. · International Breast Cancer Study Group Statistical Center, Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, Massachusetts. · International Breast Cancer Study Group Coordinating Center and Central Pathology Office, Bern, Switzerland. · Institute of Molecular Medicine, University of Southern Denmark, Odense, Denmark6Danish Breast Cancer Cooperative Group, Copenhagen, Denmark11Department of Oncology, Odense University Hospital, Odense, Denmark12AgeCare, Odense University Hospital, Odense. · Medical Oncology Clinic, Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Service de Biostatistique et d'Epidémiologie, Gustave Roussy, Villejuif, France14INSERM U1018, CESP, Université Paris-Sud, Villejuif France. · Pubmed 26633571
  • Department of Medicine, BrEAST Data Centre, Institut Jules Bordet, and l'Université Libre de Bruxelles (U.L.B.), Boulevard de Waterloo 121, 1000 Brussels, Belgium. · Department of Medical Oncology, U.O. Oncologia Medica 2, IRCCS AOU San Martino-IST, Largo Rosanna Benzi 10, 16132 Genova, Italy. · Data Centre, Institut Jules Bordet, and l'Université Libre de Bruxelles (U.L.B.), Boulevard de Waterloo 121, 1000 Brussels, Belgium. · Department of Oncology, KU Leuven-University of Leuven, University Hospitals Leuven, B-3000 Leuven, Belgium. · Department of Medical Oncology, U.O. Sviluppo Terapie Innovative, IRCCS AOU San Martino-IST, Largo Rosanna Benzi 10, 16132 Genova, Italy. · Department of Medical and Biological Sciences, University of Udine, Piazzale Santa Maria della Misericordia 15, 33010 Udine, Italy. · Department of Oncology, University Hospital of Udine, Piazzale Santa Maria della Misericordia 15, 33010 Udine, Italy. · Department of Imaging and Pathology, Laboratory of Translational Cell & Tissue Research, KU Leuven-University of Leuven, B-3000 Leuven, Belgium. · Department of Pathology, KU Leuven-University of Leuven, University Hospitals Leuven, B-3000 Leuven, Belgium. · Department of General Medical Oncology, KU Leuven-University of Leuven, University Hospitals Leuven, B-3000 Leuven, Belgium. · Department of Gynecology and Obstetrics, KU Leuven-University of Leuven, University Hospitals Leuven, B-3000 Leuven, Belgium. · Pubmed 27802449
  • Obstetrics and Gynecology Department, Erasme Hospital, Brussels, Belgium; Research Laboratory on Human Reproduction, Université Libre de Bruxelles, Brussels, Belgium. Electronic address: · Research Laboratory on Human Reproduction, Université Libre de Bruxelles, Brussels, Belgium. Electronic address: · BrEAST Data Centre, Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Boulevard de Waterloo, 121, Brussels, Belgium. Electronic address: · Pubmed 26681116
2015
  • Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Pubmed 26352893
  • BrEAST Data Centre, Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Boulevard de Waterloo 125, B-1000 Brussels, Belgium. · Pubmed 25286972
  • Department of Medicine, BrEAST Data Centre, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Peter MacCallum Cancer Centre, Melbourne, Australia; Australia and New Zealand Breast Cancer Trials Group Newcastle, Australia; International Breast Cancer Study Group, Bern, Switzerland. · Swedish Breast Cancer Group, Universitetssjukhuset, Linkoping, Sweden. · Grupo Oncologico Cooperativo Chileno De Investigacion, Clinica Las Condes, Santiago, Chile. · International Drug Development Institute, Louvain-La-Neuve, Belgium. · University of Milan School of Medicine, and Department of Pathology, European Institute of Oncology, Milan, Italy. · Data Management Unit, Institut Jules Bordet, Université Libre de Bruxelles, Belgium. · Department of Oncology, Copenhagen University Hospital Rigshospitalet, and Danish Breast Cancer Cooperative Group, Copenhagen, Denmark. · Department of Hematology and Medical Oncology, Hospital Clínico Universitario de Valencia/INCLIVA, Universidad de Valencia, Spain(1). · Department of Surgery and Comprehensive Cancer Center, Medical University of Vienna, Austrian Breast and Colorectal Cancer Study Group, Vienna, Austria. · European Institute of Oncology, Milan, Italy; International Breast Cancer Study Group (IBCSG), Bern, Switzerland. · Sandro Pitigliani' Medical Oncology Department, Hospital of Prato, Istituto Toscano Tumori, Prato, Italy. · Medical Oncology Department, Hospital Santa Creu i Sant Pau, Medicine Department, Universitat Autònoma, Barcelona, Spain(1). · Department of Medical Oncology, University Hospital 12 de Octubre, Madrid, Spain. · St Vincet's University Hospital, Dublin 4, Ireland. Electronic address: · Pubmed 26074397
  • Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Boulevard de Waterloo, 121, Brussels, Belgium. · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Boulevard de Waterloo, 121, Brussels, Belgium. · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Boulevard de Waterloo, 121, Brussels, Belgium. · Department of Internal Medicine, University of Genova and IRCCS AOU San Martino - IST, Genoa, Italy. · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Boulevard de Waterloo, 121, Brussels, Belgium. · Pubmed 26467651
  • Obstetrics and Gynecology Department, Erasme Hospital, Brussels, Belgium; Research Laboratory on Human Reproduction, Université Libre de Bruxelles, Brussels, Belgium. Electronic address: · Danish Breast Cancer Cooperative Group, Righospitalet, Copenhagen, Denmark. Electronic address: · Fertility and Procreation in Oncology Unit, European Institute of Oncology, Milan, Italy. Electronic address: · Breast Cancer Unit, Service of Gynecology, Hospital Val d'Hebron, Barcelona, Spain. Electronic address: · Department of Oncology, Macerata Hospital, Italy. Electronic address: · Department of Gynaecology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark. Electronic address: · Research Laboratory on Human Reproduction, Université Libre de Bruxelles, Brussels, Belgium. Electronic address: · BrEAST Data Centre, Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. Electronic address: · Pubmed 26070684
  • BrEAST Data Centre, Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. Electronic address: · Division of Pathology, European Institute of Oncology, Milan, Italy. · Fertility and Procreation Unit, Department of Gynecology Oncology, European Institute of Oncology, Milan, Italy. · Division of Pathology, European Institute of Oncology, Milan, Italy; University of Milan, School of Medicine, Milan, Italy. · Division of Clinical Medicine and Research, Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, Victoria, Australia. · Pubmed 25702955
  • Oncology Institute of Southern Switzerland (IOSI), 6500 Bellinzona, Switzerland; International Breast Cancer Study Group (IBCSG), Effingerstrasse 40, 3008 Bern, Switzerland. Electronic address: · International Breast Cancer Study Group (IBCSG), Effingerstrasse 40, 3008 Bern, Switzerland. · Oncology Institute of Southern Switzerland (IOSI), 6500 Bellinzona, Switzerland. · School of Surgery, University of Western Australia, Perth, WA 6009, Australia. · Fertility & Procreation Unit, Division of Gynecologic Oncology, European Institute of Oncology (IEO), Via Ripamonti 435, 20141 Milan, Italy. · Breast Unit, Champalimaud Cancer Centre, Av. De Brasília, Doca de Pedrouços, 1400 - 038 Lisbon, Portugal. · Breast Cancer Service for Young Women, Oncology Institute, Sheba Medical Center, Tel Hashomer, 52621, Israel. · Woman and Fetal Imaging Clinic (WAFI), 2 Mohamed Farid Wagdy St., Suite41 Manial Al Roda Island, Cairo, Egypt. · Ospedale Multimedica, Viale Piemonte 70, Castellanza, VA, Italy. · Department of Oncology, King Abdul Aziz Medical City for National Guard, Riyadh, Saudi Arabia. · Oncology Department Macerata Hospital, Via S. Lucia 1, 62100 Macerata, Italy. · Sunnybrook Health Sciences Centre, Odette Cancer Centre, Medical Oncology, 2075 Bayview Avenue, Toronto, ON M4N 3M5, Canada. · Hereditary Cancer Clinic, Dpt of Medical Oncology, University Hospital of Heraklion, Voutes, Box 1352, Heraklion 71110, Greece. · Greeceo Unité d'oncologie, Ensemble hospitalier de la Côte, Hôpital de Morges, Morges and Centre pluridisciplinaire d'oncologie (CePO), CHUV, Lausanne, Switzerland. · CHUV-Centre d'Oncologie, Rue du Bugnon 46, 1011 Lausanne, Switzerland. · Universitätsklinik und Poliklinik für Medizinische Onkologie/Brust-und Tumor Zentrum der Frauenklinik, Inselspital, Freiburgstrasse, 3010 Bern, Switzerland. · IBCSG Statistical Center, Dana-Farber Cancer Institute, Frontier Science and Technology Research Foundation, Boston, MA, USA. · International Breast Cancer Study Group (IBCSG), Effingerstrasse 40, 3008 Bern, Switzerland; Program of Breast Health, European Institute of Oncology (IEO), Via Ripamonti, 435, 20141 Milano, Italy. · Division of Medical Oncology, University of Washington, Seattle, WA, USA. · Department of Medicine, BrEAST Data Centre, Institut Jules Bordet, Université Libre de, Bruxelles, Brussels, Belgium. · Dana-Farber Cancer Institute, 450 Brookline Avenue, Yawkey 12, Boston, MA 02215, USA. · Pubmed 25662412
2014
  • BrEAST Data Center, Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · BrEAST Data Center, Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · BrEAST Data Center, Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Pubmed 25336696
  • Institut Jules Bordet and Breast European Adjuvant Study Team, Brussels, Belgium. Electronic address: · Frontier Science (Scotland) Ltd, Grampian View, Kincraig, Kingussie, UK. · Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Istituto Nazionale del Tumori, Milan, Italy; SOLTI Breast Cancer Research Group, Spain. · GlaxoSmithKline, Collegeville, PA, USA. · Clinic for Gynaecology, Gynaecologic Oncology and Obstetrics and Breast Cancer Centre, HELIOS Klinikum Berlin, Buch, Germany. · Sana Klinikum Offenbach, Offenbach, Germany. · National Institute of Oncology, Budapest, Hungary. · Royal Marsden Hospital, London, UK; Institute of Cancer Research, London, UK. · Patricia Ritchie Centre for Cancer Care and Research, The University of Sydney, Mater Hospital, North Sydney, NSW, Australia. · Cancer Hospital, Chinese Academy of Medical Sciences, Beijing, China. · PUC-RS School of Medicine, Porto Alegre, Brazil. · Mayo Clinic, Jacksonville, FL, USA. · Institut Jules Bordet and Breast European Adjuvant Study Team, Brussels, Belgium. · Asian Medical Center, University of Ulsan College of Medicine, Seoul, South Korea. · Kliniken Essen-Mitte, Essen, Germany. · National Taiwan University Hospital, Taipei, Taiwan. · Clinique St-Elisabeth, Namur, Belgium. · Mackay Memorial Hospital, Taipei, Taiwan. · Kashirskoye Shosse, Moscow, Russia. · Cancer Institute "Prof Dr Ion Chiricuta", Cluj-Napoca, Romania. · Department of Medical Oncology, University of Pretoria, Pretoria, South Africa. · Odessa Oncology Centre, Odessa, Ukraine. · Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute and Frontier Science and Technology Research Foundation, Boston, MA, USA. · University Hospital Kiel, Kiel, Germany. · Memorial Sloan-Kettering Cancer Center, New York, NY, USA. · Pubmed 25130998
  • Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. · Oncology Institute of Southern Switzerland, Bellinzona, Switzerland; Breast Unit of Southern Switzerland, Bellinzona, Switzerland. · King Abdulaziz Medical City for National Guard, Riyadh, Saudi Arabia. · Luzerner Kantonsspital, Lucerne, Switzerland. · University Hospitals of Leuven, Leuven, Belgium. · Department of Medicine, BrEAST Data Centre, Jules Bordet Institute, Université Libre de Bruxelles, Brussels, Belgium. · European School of Oncology, Milan, Italy. · Institut Gustave Roussy, Villejuif, France. · Europa Donna, London, United Kingdom. · European Institute of Oncology, Milan, Italy. · Breast Center, Dept. OB&GYN, University of Munich (LMU), Munich, Germany. · Mater Misericordiae University Hospital, Dublin, Ireland. · German Breast Group, GBG Forschungs GmbH, Neu-Isenburg, Germany; Sana Klinikum Offenbach, Germany. · Sheba Medical Center, Ramat Gan, Israel. · European School of Oncology, Milan, Italy; European Institute of Oncology, Milan, Italy. · Sheba Medical Center, Tel Hashomer, Israel. · Breast Unit, Champalimaud Cancer Center, Lisbon, Portugal; European Institute of Oncology, Milan, Italy. Electronic address: · Pubmed 24767882
  • BrEAST Data Centre, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium · BrEAST Data Centre, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Frontier Science, Kincraig, Kingussie, Scotland. · Pubmed 25225439
2013
  • Department of Medicine, BrEAST Data Centre, Institut Jules Bordet, Université Libre de Bruxelles, Boulevard de Waterloo, 121, 1000 Brussels, Belgium. Electronic address: · Pubmed 24139068
  • Breast Cancer Translational Research Laboratory, J.C. Heuson, Université Libre de Bruxelles, Institut Jules Bordet, Brussels, Belgium; Department of Medicine, BrEAST Data Centre, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Pubmed 24060577
  • Jose Baselga, Memorial Sloan-Kettering Cancer Center, NY · James G. Greger Jr, GlaxoSmithKline, Collegeville, PA · Hatem A. Azim Jr, Martine Piccart, Evandro de Azambuja, BrEAST Data Centre, Institut Jules Bordet, Université Libre de Bruxelles · Phuong Dinh, Breast International Group, Brussels · Peter Vuylsteke, Sint-Elisabeth Hospital, Namur, Belgium · Dominique Agbor-tarh, Ian Bradbury, Frontier Science, Kincraig, Kingussie, Scotland · Ian Smith, Royal Marsden Hospital, and Institute of Cancer Research, London, United Kingdom · Serena Di Cosimo, IRCCS Fondazione Instituto Nazionale dei Tumori, Milan, Italy · Serena Di Cosimo, SOLTI Breast Cancer Research Group, Barcelona, Spain · Christian Jackisch, Kilinikum Offenbach, Offenbach · Bahriye Aktas, Kliniken Essen-Mitte, Evang, Essen · Holger Eidtmann, University Hospital Kiel, Kiel, Germany · Sung-Bae Kim, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea · Chiun-Sheng Huang, National Taiwan University Hospital · Ruey Kuen Hsieh, Mackey Memorial Hospital, Taipei, Taiwan · and Lydia Dreosti, University of Pretoria, Pretoria, South Africa. · Pubmed 24248687
  • Breast Cancer Translational Research Laboratory, JC Heuson, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Pubmed 23638089
  • Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Pubmed 23169515
2012
  • Breast Cancer Translational Research Laboratory J.C. Heuson, Université Libre de Bruxelles, Institut Jules Bordet, 1000 Brussels, Belgium. · Pubmed 22785217
  • Department of Medical Oncology, Institut Jules Bordet and l'Université Libre de Bruxelles, Boulevard de Waterloo 121, 1000 Brussels, Belgium. · Pubmed 22367645
  • Breast Cancer Translational Research Laboratory (BCTL) J.C. Heuson, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Pubmed 22261811
2011
  • Department of Medical Oncology, Jules Bordet Institute, Boulevard de Waterloo 121, 1000 Brussels, Belgium. · Pubmed 21342046
2016
  • Department of Medicine, Breast European Adjuvant Study Team (BrEAST) Data Centre, Institut Jules Bordet, Université Libre de Bruxelles (ULB), Brussels, Belgium (AS, EdA, MP, HAAJr); Frontier Science (Scotland) Ltd, Grampian View, Kincraig, Kingussie, UK (DAt, IB, CC); Novartis Pharmaceuticals Corporation, East Hanover, NJ (YH); Alliance Statistics and Data Center, Mayo Clinic, Section of Biostatistics, Scottsdale, AZ (ACD); Sunnybrook Odette Cancer Centre, the University of Toronto and the NCIC Clinical Trials Group, Toronto, Ontario, Canada (KIP); The Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD (ACW); Sana Klinikum Offenbach, Offenbach, Germany (CJ); National Institute of Oncology, Budapest, Hungary (IL); Helios Klinikum Berlin-Buch, Berlin, Germany (MU); Royal Marsden Hospital NHS Trust, Sutton/Surrey, UK (IS); Patricia Ritchie Centre for Cancer Care and Research, The University of Sydney, Mater Hospital, North Sydney, Australia (FB); Cancer Hospital, Chinese Academy of Medical Sciences, Beijing, China (BX); Instituto Nacional de Enfermedades Neoplasicas, Lima, Peru (HG); Mayo Clinic, Jacksonville, FL (EAP). · Department of Medicine, Breast European Adjuvant Study Team (BrEAST) Data Centre, Institut Jules Bordet, Université Libre de Bruxelles (ULB), Brussels, Belgium (AS, EdA, MP, HAAJr); Frontier Science (Scotland) Ltd, Grampian View, Kincraig, Kingussie, UK (DAt, IB, CC); Novartis Pharmaceuticals Corporation, East Hanover, NJ (YH); Alliance Statistics and Data Center, Mayo Clinic, Section of Biostatistics, Scottsdale, AZ (ACD); Sunnybrook Odette Cancer Centre, the University of Toronto and the NCIC Clinical Trials Group, Toronto, Ontario, Canada (KIP); The Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD (ACW); Sana Klinikum Offenbach, Offenbach, Germany (CJ); National Institute of Oncology, Budapest, Hungary (IL); Helios Klinikum Berlin-Buch, Berlin, Germany (MU); Royal Marsden Hospital NHS Trust, Sutton/Surrey, UK (IS); Patricia Ritchie Centre for Cancer Care and Research, The University of Sydney, Mater Hospital, North Sydney, Australia (FB); Cancer Hospital, Chinese Academy of Medical Sciences, Beijing, China (BX); Instituto Nacional de Enfermedades Neoplasicas, Lima, Peru (HG); Mayo Clinic, Jacksonville, FL (EAP) · Pubmed 27098150
  • From the Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium; University of Pittsburgh Cancer Institute and UPMC Cancer Center, Pittsburgh, PA; Department of Oncology, Mayo Clinic, Rochester, MN. · Pubmed 27249683
2014
  • Department of MedicineInstitut Jules Bordet, BrEAST Data Centre, Université Libre de Bruxelles (ULB), Boulevard de Waterloo, 121, 1000 Brussels, BelgiumBreast Cancer Translational Research Laboratory (BCTL) J. C. HeusonInstitut Jules Bordet, Université Libre de Bruxelles (ULB), Brussels, BelgiumFertility and Procreation UnitDepartment of Gynecologic Oncology, European Institute of Oncology, Milan, ItalyTranslational Breast Cancer Genomic LabCancer Therapeutics Program, Peter MacCallum Cancer Centre, East Melbourne, Victoria, AustraliaSir Peter MacCallum Department of OncologyUniversity of Melbourne, Parkville, Victoria, AustraliaVesalius Research CentreVIB, Leuven, BelgiumLaboratory of Translational GeneticsDepartment of Oncology, University of Leuven, Leuven, BelgiumDepartment of PathologyDivision of Epidemiology and BiostatisticsEuropean Institute of Oncology, Milan, ItalyDepartment of MedicineMedical Oncology Clinic, Institut Jules Bordet, Université Libre de Bruxelles (ULB), Brussels, BelgiumDepartment of MedicineInstitut Jules Bordet, BrEAST Data Centre, Université Libre de Bruxelles (ULB), Boulevard de Waterloo, 121, 1000 Brussels, BelgiumBreast Cancer Translational Research Laboratory (BCTL) J. C. HeusonInstitut Jules Bordet, Université Libre de Bruxelles (ULB), Brussels, BelgiumFertility and Procreation UnitDepartment of Gynecologic Oncology, European Institute of Oncology, Milan, ItalyTranslational Breast Cancer Genomic LabCancer Therapeutics Program, Peter MacCallum Cancer Centre, East Melbourne, Victoria, AustraliaSir Peter MacCallum Department of OncologyUniversity of Melbourne, Parkville, Victoria, AustraliaVesalius Research CentreVIB, Leuven, BelgiumLaboratory of Translational GeneticsDepartment of Oncology, University of Leuven, Leuven, BelgiumDepartment of PathologyDivision of Epidemiology and BiostatisticsEuropean Institute of Oncology, Milan, ItalyDepartment of MedicineMedical Oncology Clinic, Institut Jules Bordet, Université Libre de Bruxel · Department of MedicineInstitut Jules Bordet, BrEAST Data Centre, Université Libre de Bruxelles (ULB), Boulevard de Waterloo, 121, 1000 Brussels, BelgiumBreast Cancer Translational Research Laboratory (BCTL) J. C. HeusonInstitut Jules Bordet, Université Libre de Bruxelles (ULB), Brussels, BelgiumFertility and Procreation UnitDepartment of Gynecologic Oncology, European Institute of Oncology, Milan, ItalyTranslational Breast Cancer Genomic LabCancer Therapeutics Program, Peter MacCallum Cancer Centre, East Melbourne, Victoria, AustraliaSir Peter MacCallum Department of OncologyUniversity of Melbourne, Parkville, Victoria, AustraliaVesalius Research CentreVIB, Leuven, BelgiumLaboratory of Translational GeneticsDepartment of Oncology, University of Leuven, Leuven, BelgiumDepartment of PathologyDivision of Epidemiology and BiostatisticsEuropean Institute of Oncology, Milan, ItalyDepartment of MedicineMedical Oncology Clinic, Institut Jules Bordet, Université Libre de Bruxelles (ULB), Brussels, Belgium. · Pubmed 24825746
2012
  • Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Pubmed 22454417
2011
  • Department of Medical Oncology, Institut Jules Bordet, Universite Libre de Bruxelles, 1000 Brussels, Belgium. · Pubmed 21354372
Universite Libre de Bruxelles
2017
  • Breast Cancer Translational Research Laboratory, Institut Jules Bordet and Université Libre de Bruxelles (U.L.B.), Brussels, Belgium; Department of Medical Oncology, Institut Jules Bordet and Université Libre de Bruxelles (U.L.B.), Brussels, Belgium. Electronic address: · Fertility Clinic, Research Laboratory on Human Reproduction, CUB-Erasme, and Université Libre de Bruxelles (U.L.B.), Brussels, Belgium. · Department of Oncology and Hematology, University Hospital of Modena and Reggio Emilia, Modena, Italy. · Department of Medical Oncology, Institut Jules Bordet and Université Libre de Bruxelles (U.L.B.), Brussels, Belgium. · Fertility and Procreation Unit, Gynecologic Oncology Department, European Institute of Oncology, Milan, Italy. · Department of Medical Oncology, U.O. Sviluppo Terapie Innovative, IRCCS AOU San Martino-IST, Genova, Italy. · Pubmed 28750297
  • Hematology/Oncology Department, Hôpital du Sacré-Coeur de Montréal, Montreal, Quebec, Canada. · Frontier Science (Scotland) Ltd., Kincraig, UK. · Breast Data Center, Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Radiation Oncology Department, Hôpital Maisonneuve-Rosemont, Montreal, Quebec, Canada. · Novartis Pharma AG, Basel, Switzerland. · National Cancer Institute, Bethesda, MD, USA. · Oncology Division, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel. · Department of Oncology, Division of Cancer, Oslo University Hospital, Oslo, Norway. · Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway. · Medical Oncology Unit, Azienda Istituti Ospitalieri, Cremona, Italy. · Seattle Cancer Care Alliance, University of Washington, Seattle, WA, USA. · Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD, USA. · Case Western Reserve University, Cleveland, OH, USA. · Department of Surgery and Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria. · Department of Hematology/Oncology, Mayo Clinic, Jacksonville, FL, USA. · Pubmed 28376188
  • Amir Sonnenblick, Hadassah-Hebrew University Medical Center, Jerusalem, Israel · Dominique Agbor-Tarh and Ian Bradbury, Frontier Science, Kingussie, United Kingdom · Serena Di Cosimo Fondazione IRCCS, Istituto Nazionale dei Tumori, Milan, Italy · Hatem A. Azim Jr, Martine Piccart-Gebhart and Evandro de Azambuja, Université Libre de Bruxelles · Debora Fumagalli, Breast International Group, Brussels, Belgium · Severine Sarp, Novartis Pharma AG, Basel, Switzerland · Antonio C. Wolff, Johns Hopkins School of Medicine, Baltimore, MD · Lyndsay Harris, Case Western Reserve University School of Medicine, Cleveland, OH · Julie Gralow, Seattle Cancer Care Alliance, Seattle, WA · Alvaro Moreno-Aspitia, Mayo Clinic, Jacksonville, FL · Michael Andersson, Rigshospitalet University Hospital Copenhagen, Denmark · Judith Kroep, Leiden University Medical Center, Leiden, the Netherlands · Tanja Cufer, University Clinic Golnik Medical Faculty, Ljubljana, Slovenia · Sergio D. Simon, Hospital Israelita Albert Einstein · Sergio D. Simon, Grupo Brasileiro de Estudos do Cancer de Mama, São Paulo, Brazil · Pamela Salman, Fundación Arturo López Pérez, Santiago, Chile · Masakazu Toi, Kyoto University, Kyoto, Japan · Maccon Keane, University Hospital Galway, Galway · and Maccon Keane, Cancer Trials Ireland, Dublin, Ireland. · Pubmed 28375706
2016
  • a BrEAST Data Centre, Department of Medicine, Institut Jules Bordet , Université Libre de Bruxelles , Brussels , Belgium. · b Medicine Department, Institut Jules Bordet , Université Libre de Bruxelles , Brussels , Belgium. · Pubmed 27010772
  • Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium2Medical Oncology Clinic, Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Department of Breast and Gynecological Surgery, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Department of Pathology, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Institute of Molecular Medicine, University of Southern Denmark, Odense, Denmark6Danish Breast Cancer Cooperative Group, Copenhagen, Denmark. · Department of Pathology, European Institute of Oncology, University of Milan, Milan, Italy. · Avera Cancer Institute, Sioux Falls, South Dakota. · International Breast Cancer Study Group Statistical Center, Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, Massachusetts. · International Breast Cancer Study Group Coordinating Center and Central Pathology Office, Bern, Switzerland. · Institute of Molecular Medicine, University of Southern Denmark, Odense, Denmark6Danish Breast Cancer Cooperative Group, Copenhagen, Denmark11Department of Oncology, Odense University Hospital, Odense, Denmark12AgeCare, Odense University Hospital, Odense. · Medical Oncology Clinic, Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Service de Biostatistique et d'Epidémiologie, Gustave Roussy, Villejuif, France14INSERM U1018, CESP, Université Paris-Sud, Villejuif France. · Pubmed 26633571
  • Obstetrics and Gynecology Department, Erasme Hospital, Brussels, Belgium; Research Laboratory on Human Reproduction, Université Libre de Bruxelles, Brussels, Belgium. Electronic address: · Research Laboratory on Human Reproduction, Université Libre de Bruxelles, Brussels, Belgium. Electronic address: · BrEAST Data Centre, Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Boulevard de Waterloo, 121, Brussels, Belgium. Electronic address: · Pubmed 26681116
2015
  • Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Pubmed 26352893
  • BrEAST Data Centre, Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Boulevard de Waterloo 125, B-1000 Brussels, Belgium. · Pubmed 25286972
  • Department of Medicine, BrEAST Data Centre, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Peter MacCallum Cancer Centre, Melbourne, Australia; Australia and New Zealand Breast Cancer Trials Group Newcastle, Australia; International Breast Cancer Study Group, Bern, Switzerland. · Swedish Breast Cancer Group, Universitetssjukhuset, Linkoping, Sweden. · Grupo Oncologico Cooperativo Chileno De Investigacion, Clinica Las Condes, Santiago, Chile. · International Drug Development Institute, Louvain-La-Neuve, Belgium. · University of Milan School of Medicine, and Department of Pathology, European Institute of Oncology, Milan, Italy. · Data Management Unit, Institut Jules Bordet, Université Libre de Bruxelles, Belgium. · Department of Oncology, Copenhagen University Hospital Rigshospitalet, and Danish Breast Cancer Cooperative Group, Copenhagen, Denmark. · Department of Hematology and Medical Oncology, Hospital Clínico Universitario de Valencia/INCLIVA, Universidad de Valencia, Spain(1). · Department of Surgery and Comprehensive Cancer Center, Medical University of Vienna, Austrian Breast and Colorectal Cancer Study Group, Vienna, Austria. · European Institute of Oncology, Milan, Italy; International Breast Cancer Study Group (IBCSG), Bern, Switzerland. · Sandro Pitigliani' Medical Oncology Department, Hospital of Prato, Istituto Toscano Tumori, Prato, Italy. · Medical Oncology Department, Hospital Santa Creu i Sant Pau, Medicine Department, Universitat Autònoma, Barcelona, Spain(1). · Department of Medical Oncology, University Hospital 12 de Octubre, Madrid, Spain. · St Vincet's University Hospital, Dublin 4, Ireland. Electronic address: · Pubmed 26074397
  • Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Boulevard de Waterloo, 121, Brussels, Belgium. · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Boulevard de Waterloo, 121, Brussels, Belgium. · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Boulevard de Waterloo, 121, Brussels, Belgium. · Department of Internal Medicine, University of Genova and IRCCS AOU San Martino - IST, Genoa, Italy. · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Boulevard de Waterloo, 121, Brussels, Belgium. · Pubmed 26467651
  • Obstetrics and Gynecology Department, Erasme Hospital, Brussels, Belgium; Research Laboratory on Human Reproduction, Université Libre de Bruxelles, Brussels, Belgium. Electronic address: · Danish Breast Cancer Cooperative Group, Righospitalet, Copenhagen, Denmark. Electronic address: · Fertility and Procreation in Oncology Unit, European Institute of Oncology, Milan, Italy. Electronic address: · Breast Cancer Unit, Service of Gynecology, Hospital Val d'Hebron, Barcelona, Spain. Electronic address: · Department of Oncology, Macerata Hospital, Italy. Electronic address: · Department of Gynaecology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark. Electronic address: · Research Laboratory on Human Reproduction, Université Libre de Bruxelles, Brussels, Belgium. Electronic address: · BrEAST Data Centre, Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. Electronic address: · Pubmed 26070684
  • BrEAST Data Centre, Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. Electronic address: · Division of Pathology, European Institute of Oncology, Milan, Italy. · Fertility and Procreation Unit, Department of Gynecology Oncology, European Institute of Oncology, Milan, Italy. · Division of Pathology, European Institute of Oncology, Milan, Italy; University of Milan, School of Medicine, Milan, Italy. · Division of Clinical Medicine and Research, Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, Victoria, Australia. · Pubmed 25702955
  • Oncology Institute of Southern Switzerland (IOSI), 6500 Bellinzona, Switzerland; International Breast Cancer Study Group (IBCSG), Effingerstrasse 40, 3008 Bern, Switzerland. Electronic address: · International Breast Cancer Study Group (IBCSG), Effingerstrasse 40, 3008 Bern, Switzerland. · Oncology Institute of Southern Switzerland (IOSI), 6500 Bellinzona, Switzerland. · School of Surgery, University of Western Australia, Perth, WA 6009, Australia. · Fertility & Procreation Unit, Division of Gynecologic Oncology, European Institute of Oncology (IEO), Via Ripamonti 435, 20141 Milan, Italy. · Breast Unit, Champalimaud Cancer Centre, Av. De Brasília, Doca de Pedrouços, 1400 - 038 Lisbon, Portugal. · Breast Cancer Service for Young Women, Oncology Institute, Sheba Medical Center, Tel Hashomer, 52621, Israel. · Woman and Fetal Imaging Clinic (WAFI), 2 Mohamed Farid Wagdy St., Suite41 Manial Al Roda Island, Cairo, Egypt. · Ospedale Multimedica, Viale Piemonte 70, Castellanza, VA, Italy. · Department of Oncology, King Abdul Aziz Medical City for National Guard, Riyadh, Saudi Arabia. · Oncology Department Macerata Hospital, Via S. Lucia 1, 62100 Macerata, Italy. · Sunnybrook Health Sciences Centre, Odette Cancer Centre, Medical Oncology, 2075 Bayview Avenue, Toronto, ON M4N 3M5, Canada. · Hereditary Cancer Clinic, Dpt of Medical Oncology, University Hospital of Heraklion, Voutes, Box 1352, Heraklion 71110, Greece. · Greeceo Unité d'oncologie, Ensemble hospitalier de la Côte, Hôpital de Morges, Morges and Centre pluridisciplinaire d'oncologie (CePO), CHUV, Lausanne, Switzerland. · CHUV-Centre d'Oncologie, Rue du Bugnon 46, 1011 Lausanne, Switzerland. · Universitätsklinik und Poliklinik für Medizinische Onkologie/Brust-und Tumor Zentrum der Frauenklinik, Inselspital, Freiburgstrasse, 3010 Bern, Switzerland. · IBCSG Statistical Center, Dana-Farber Cancer Institute, Frontier Science and Technology Research Foundation, Boston, MA, USA. · International Breast Cancer Study Group (IBCSG), Effingerstrasse 40, 3008 Bern, Switzerland; Program of Breast Health, European Institute of Oncology (IEO), Via Ripamonti, 435, 20141 Milano, Italy. · Division of Medical Oncology, University of Washington, Seattle, WA, USA. · Department of Medicine, BrEAST Data Centre, Institut Jules Bordet, Université Libre de, Bruxelles, Brussels, Belgium. · Dana-Farber Cancer Institute, 450 Brookline Avenue, Yawkey 12, Boston, MA 02215, USA. · Pubmed 25662412
2014
  • BrEAST Data Center, Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · BrEAST Data Center, Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · BrEAST Data Center, Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Pubmed 25336696
  • Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. · Oncology Institute of Southern Switzerland, Bellinzona, Switzerland; Breast Unit of Southern Switzerland, Bellinzona, Switzerland. · King Abdulaziz Medical City for National Guard, Riyadh, Saudi Arabia. · Luzerner Kantonsspital, Lucerne, Switzerland. · University Hospitals of Leuven, Leuven, Belgium. · Department of Medicine, BrEAST Data Centre, Jules Bordet Institute, Université Libre de Bruxelles, Brussels, Belgium. · European School of Oncology, Milan, Italy. · Institut Gustave Roussy, Villejuif, France. · Europa Donna, London, United Kingdom. · European Institute of Oncology, Milan, Italy. · Breast Center, Dept. OB&GYN, University of Munich (LMU), Munich, Germany. · Mater Misericordiae University Hospital, Dublin, Ireland. · German Breast Group, GBG Forschungs GmbH, Neu-Isenburg, Germany; Sana Klinikum Offenbach, Germany. · Sheba Medical Center, Ramat Gan, Israel. · European School of Oncology, Milan, Italy; European Institute of Oncology, Milan, Italy. · Sheba Medical Center, Tel Hashomer, Israel. · Breast Unit, Champalimaud Cancer Center, Lisbon, Portugal; European Institute of Oncology, Milan, Italy. Electronic address: · Pubmed 24767882
  • BrEAST Data Centre, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium · BrEAST Data Centre, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Frontier Science, Kincraig, Kingussie, Scotland. · Pubmed 25225439
2013
  • Department of Medicine, BrEAST Data Centre, Institut Jules Bordet, Université Libre de Bruxelles, Boulevard de Waterloo, 121, 1000 Brussels, Belgium. Electronic address: · Pubmed 24139068
  • Breast Cancer Translational Research Laboratory, J.C. Heuson, Université Libre de Bruxelles, Institut Jules Bordet, Brussels, Belgium; Department of Medicine, BrEAST Data Centre, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Pubmed 24060577
  • Jose Baselga, Memorial Sloan-Kettering Cancer Center, NY · James G. Greger Jr, GlaxoSmithKline, Collegeville, PA · Hatem A. Azim Jr, Martine Piccart, Evandro de Azambuja, BrEAST Data Centre, Institut Jules Bordet, Université Libre de Bruxelles · Phuong Dinh, Breast International Group, Brussels · Peter Vuylsteke, Sint-Elisabeth Hospital, Namur, Belgium · Dominique Agbor-tarh, Ian Bradbury, Frontier Science, Kincraig, Kingussie, Scotland · Ian Smith, Royal Marsden Hospital, and Institute of Cancer Research, London, United Kingdom · Serena Di Cosimo, IRCCS Fondazione Instituto Nazionale dei Tumori, Milan, Italy · Serena Di Cosimo, SOLTI Breast Cancer Research Group, Barcelona, Spain · Christian Jackisch, Kilinikum Offenbach, Offenbach · Bahriye Aktas, Kliniken Essen-Mitte, Evang, Essen · Holger Eidtmann, University Hospital Kiel, Kiel, Germany · Sung-Bae Kim, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea · Chiun-Sheng Huang, National Taiwan University Hospital · Ruey Kuen Hsieh, Mackey Memorial Hospital, Taipei, Taiwan · and Lydia Dreosti, University of Pretoria, Pretoria, South Africa. · Pubmed 24248687
  • Breast Cancer Translational Research Laboratory, JC Heuson, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Pubmed 23638089
  • Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Pubmed 23169515
2012
  • Breast Cancer Translational Research Laboratory J.C. Heuson, Université Libre de Bruxelles, Institut Jules Bordet, 1000 Brussels, Belgium. · Pubmed 22785217
  • Breast Cancer Translational Research Laboratory (BCTL) J.C. Heuson, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Pubmed 22261811
2016
  • Department of Medicine, Breast European Adjuvant Study Team (BrEAST) Data Centre, Institut Jules Bordet, Université Libre de Bruxelles (ULB), Brussels, Belgium (AS, EdA, MP, HAAJr); Frontier Science (Scotland) Ltd, Grampian View, Kincraig, Kingussie, UK (DAt, IB, CC); Novartis Pharmaceuticals Corporation, East Hanover, NJ (YH); Alliance Statistics and Data Center, Mayo Clinic, Section of Biostatistics, Scottsdale, AZ (ACD); Sunnybrook Odette Cancer Centre, the University of Toronto and the NCIC Clinical Trials Group, Toronto, Ontario, Canada (KIP); The Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD (ACW); Sana Klinikum Offenbach, Offenbach, Germany (CJ); National Institute of Oncology, Budapest, Hungary (IL); Helios Klinikum Berlin-Buch, Berlin, Germany (MU); Royal Marsden Hospital NHS Trust, Sutton/Surrey, UK (IS); Patricia Ritchie Centre for Cancer Care and Research, The University of Sydney, Mater Hospital, North Sydney, Australia (FB); Cancer Hospital, Chinese Academy of Medical Sciences, Beijing, China (BX); Instituto Nacional de Enfermedades Neoplasicas, Lima, Peru (HG); Mayo Clinic, Jacksonville, FL (EAP). · Department of Medicine, Breast European Adjuvant Study Team (BrEAST) Data Centre, Institut Jules Bordet, Université Libre de Bruxelles (ULB), Brussels, Belgium (AS, EdA, MP, HAAJr); Frontier Science (Scotland) Ltd, Grampian View, Kincraig, Kingussie, UK (DAt, IB, CC); Novartis Pharmaceuticals Corporation, East Hanover, NJ (YH); Alliance Statistics and Data Center, Mayo Clinic, Section of Biostatistics, Scottsdale, AZ (ACD); Sunnybrook Odette Cancer Centre, the University of Toronto and the NCIC Clinical Trials Group, Toronto, Ontario, Canada (KIP); The Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD (ACW); Sana Klinikum Offenbach, Offenbach, Germany (CJ); National Institute of Oncology, Budapest, Hungary (IL); Helios Klinikum Berlin-Buch, Berlin, Germany (MU); Royal Marsden Hospital NHS Trust, Sutton/Surrey, UK (IS); Patricia Ritchie Centre for Cancer Care and Research, The University of Sydney, Mater Hospital, North Sydney, Australia (FB); Cancer Hospital, Chinese Academy of Medical Sciences, Beijing, China (BX); Instituto Nacional de Enfermedades Neoplasicas, Lima, Peru (HG); Mayo Clinic, Jacksonville, FL (EAP) · Pubmed 27098150
  • From the Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium; University of Pittsburgh Cancer Institute and UPMC Cancer Center, Pittsburgh, PA; Department of Oncology, Mayo Clinic, Rochester, MN. · Pubmed 27249683
2014
  • Department of MedicineInstitut Jules Bordet, BrEAST Data Centre, Université Libre de Bruxelles (ULB), Boulevard de Waterloo, 121, 1000 Brussels, BelgiumBreast Cancer Translational Research Laboratory (BCTL) J. C. HeusonInstitut Jules Bordet, Université Libre de Bruxelles (ULB), Brussels, BelgiumFertility and Procreation UnitDepartment of Gynecologic Oncology, European Institute of Oncology, Milan, ItalyTranslational Breast Cancer Genomic LabCancer Therapeutics Program, Peter MacCallum Cancer Centre, East Melbourne, Victoria, AustraliaSir Peter MacCallum Department of OncologyUniversity of Melbourne, Parkville, Victoria, AustraliaVesalius Research CentreVIB, Leuven, BelgiumLaboratory of Translational GeneticsDepartment of Oncology, University of Leuven, Leuven, BelgiumDepartment of PathologyDivision of Epidemiology and BiostatisticsEuropean Institute of Oncology, Milan, ItalyDepartment of MedicineMedical Oncology Clinic, Institut Jules Bordet, Université Libre de Bruxelles (ULB), Brussels, BelgiumDepartment of MedicineInstitut Jules Bordet, BrEAST Data Centre, Université Libre de Bruxelles (ULB), Boulevard de Waterloo, 121, 1000 Brussels, BelgiumBreast Cancer Translational Research Laboratory (BCTL) J. C. HeusonInstitut Jules Bordet, Université Libre de Bruxelles (ULB), Brussels, BelgiumFertility and Procreation UnitDepartment of Gynecologic Oncology, European Institute of Oncology, Milan, ItalyTranslational Breast Cancer Genomic LabCancer Therapeutics Program, Peter MacCallum Cancer Centre, East Melbourne, Victoria, AustraliaSir Peter MacCallum Department of OncologyUniversity of Melbourne, Parkville, Victoria, AustraliaVesalius Research CentreVIB, Leuven, BelgiumLaboratory of Translational GeneticsDepartment of Oncology, University of Leuven, Leuven, BelgiumDepartment of PathologyDivision of Epidemiology and BiostatisticsEuropean Institute of Oncology, Milan, ItalyDepartment of MedicineMedical Oncology Clinic, Institut Jules Bordet, Université Libre de Bruxel · Department of MedicineInstitut Jules Bordet, BrEAST Data Centre, Université Libre de Bruxelles (ULB), Boulevard de Waterloo, 121, 1000 Brussels, BelgiumBreast Cancer Translational Research Laboratory (BCTL) J. C. HeusonInstitut Jules Bordet, Université Libre de Bruxelles (ULB), Brussels, BelgiumFertility and Procreation UnitDepartment of Gynecologic Oncology, European Institute of Oncology, Milan, ItalyTranslational Breast Cancer Genomic LabCancer Therapeutics Program, Peter MacCallum Cancer Centre, East Melbourne, Victoria, AustraliaSir Peter MacCallum Department of OncologyUniversity of Melbourne, Parkville, Victoria, AustraliaVesalius Research CentreVIB, Leuven, BelgiumLaboratory of Translational GeneticsDepartment of Oncology, University of Leuven, Leuven, BelgiumDepartment of PathologyDivision of Epidemiology and BiostatisticsEuropean Institute of Oncology, Milan, ItalyDepartment of MedicineMedical Oncology Clinic, Institut Jules Bordet, Université Libre de Bruxelles (ULB), Brussels, Belgium. · Pubmed 24825746
2012
  • Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Pubmed 22454417
2011
  • Department of Medical Oncology, Institut Jules Bordet, Universite Libre de Bruxelles, 1000 Brussels, Belgium. · Pubmed 21354372
European Institute of Oncology
2012
  • Department of Medicine, European Institute of Oncology, Via Ripamonti 435, Milan, Italy. · Pubmed 22171586
2010
  • Department of Medicine, Division of Haematology Oncology, European Institute of Oncology, Via Ripamonti 435, 20141 Milan, Italy. · Pubmed 21078487
2014
  • Department of MedicineInstitut Jules Bordet, BrEAST Data Centre, Université Libre de Bruxelles (ULB), Boulevard de Waterloo, 121, 1000 Brussels, BelgiumBreast Cancer Translational Research Laboratory (BCTL) J. C. HeusonInstitut Jules Bordet, Université Libre de Bruxelles (ULB), Brussels, BelgiumFertility and Procreation UnitDepartment of Gynecologic Oncology, European Institute of Oncology, Milan, ItalyTranslational Breast Cancer Genomic LabCancer Therapeutics Program, Peter MacCallum Cancer Centre, East Melbourne, Victoria, AustraliaSir Peter MacCallum Department of OncologyUniversity of Melbourne, Parkville, Victoria, AustraliaVesalius Research CentreVIB, Leuven, BelgiumLaboratory of Translational GeneticsDepartment of Oncology, University of Leuven, Leuven, BelgiumDepartment of PathologyDivision of Epidemiology and BiostatisticsEuropean Institute of Oncology, Milan, ItalyDepartment of MedicineMedical Oncology Clinic, Institut Jules Bordet, Université Libre de Bruxelles (ULB), Brussels, BelgiumDepartment of MedicineInstitut Jules Bordet, BrEAST Data Centre, Université Libre de Bruxelles (ULB), Boulevard de Waterloo, 121, 1000 Brussels, BelgiumBreast Cancer Translational Research Laboratory (BCTL) J. C. HeusonInstitut Jules Bordet, Université Libre de Bruxelles (ULB), Brussels, BelgiumFertility and Procreation UnitDepartment of Gynecologic Oncology, European Institute of Oncology, Milan, ItalyTranslational Breast Cancer Genomic LabCancer Therapeutics Program, Peter MacCallum Cancer Centre, East Melbourne, Victoria, AustraliaSir Peter MacCallum Department of OncologyUniversity of Melbourne, Parkville, Victoria, AustraliaVesalius Research CentreVIB, Leuven, BelgiumLaboratory of Translational GeneticsDepartment of Oncology, University of Leuven, Leuven, BelgiumDepartment of PathologyDivision of Epidemiology and BiostatisticsEuropean Institute of Oncology, Milan, ItalyDepartment of MedicineMedical Oncology Clinic, Institut Jules Bordet, Université Libre de Bruxel · Department of MedicineInstitut Jules Bordet, BrEAST Data Centre, Université Libre de Bruxelles (ULB), Boulevard de Waterloo, 121, 1000 Brussels, BelgiumBreast Cancer Translational Research Laboratory (BCTL) J. C. HeusonInstitut Jules Bordet, Université Libre de Bruxelles (ULB), Brussels, BelgiumFertility and Procreation UnitDepartment of Gynecologic Oncology, European Institute of Oncology, Milan, ItalyTranslational Breast Cancer Genomic LabCancer Therapeutics Program, Peter MacCallum Cancer Centre, East Melbourne, Victoria, AustraliaSir Peter MacCallum Department of OncologyUniversity of Melbourne, Parkville, Victoria, AustraliaVesalius Research CentreVIB, Leuven, BelgiumLaboratory of Translational GeneticsDepartment of Oncology, University of Leuven, Leuven, BelgiumDepartment of PathologyDivision of Epidemiology and BiostatisticsEuropean Institute of Oncology, Milan, ItalyDepartment of MedicineMedical Oncology Clinic, Institut Jules Bordet, Université Libre de Bruxelles (ULB), Brussels, Belgium. · Pubmed 24825746
2013
  • Fertility and Procreation in Oncology Unit, Department of Medicine, European Institute of Oncology, Milan, Italy. · Pubmed 23199900
  • Division of Plastic Surgery, European Institute of Oncology, Via Ripamonti, 435 - 20141 Milano, Italy; Faculty of Medicine, Mahidol University, Siriraj Hospital, Bangkok, Thailand. Electronic address: · Pubmed 23871328
21 Other Locations Show
Yearly article counts 153810787310
 
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.